





















Hydrogels	 are	of	 great	 interest	due	 to	 their	 ability	 to	encapsulate	and	deliver	bioactive	
molecules,	mimic	the	extracellular	matrix	(ECM)	and	act	as	an	artificial	3D	scaffold.	Here	
we	report	multi-component	hydrogels	based	on	low-molecular-weight	gelators	(LMWGs)	
and	 polymer	 gelators	 (PGs)	 incorporating	 heparin	 that	 can	 bind	 to	 self-assembled	
molecules,	and	their	potential	for	controlled	release	and	to	mimic	the	ECM.	These	multi-





head	 group	 connected	 via	 an	 amide	 linkage	 to	 different	 saturated	 fatty	 acids.	 Self-
assembled	 C14-DAPMA	 and	 C16-DAPMA	 formed	 highly	 organised	 polycrystalline	
assemblies	with	heparin,	proving	 that	 the	micelles	 remain	 intact	during	 the	hierarchical	
assembly	process.	C16-DAPMA	proved	to	be	the	most	charge-efficient	heparin	binder,	also	
with	 the	 lowest	 critical	 aggregation	 concentration,	 with	 high	 stability	 when	 free	 and	
solution	and	when	electrostatically	interacting	with	heparin.		
	
Two	 dibenzylidene-D-sorbitol	 (DBS)	 derivatives	 capable	 of	 forming	 hydrogels	 are	 then	
introduced:	 a	 pH-activated	 LMWG	 (DBS-COOH)	 and	 a	 thermally-activated	 LWMG	 (DBS-
CONHNH2).	The	 incorporation	and	release	of	heparin	 from	the	LMWGs	hydrogels	 in	the	
presence	and	absence	of	C16-DAPMA,	and	from	hybrid	hydrogels	consisting	of	one	of	the	
LMWGs	 and	 a	 PG	 -	 agarose	 is	 reported.	 The	 rate	 of	 heparin	 release	 can	 be	 controlled	
through	 network	 density	 and	 composition,	 and	 control	 of	 the	 release	 surface	 area	 to	
volume	ratio,	while	the	presence	of	C16-DAPMA	inhibits	heparin	release.	Characterisation	
of	 this	 multi-component	 complexes	 (LMWG	 +	 Heparin	 +	 C16-DAPMA)	 showed	 the	
orthogonal	 self-assembly	 of	 each	 individual	 component	 within	 one	 single	 system.	
Cytocompatilibity	 of	 the	 multi-component	 hydrogels	 is	 reported.	 Heparin	 was	 then	
incorporated	and	released	from	three	different	hydrogels	based	on	triamide	cyclohexane	
derivatives.	From	these,	a	positively	charged	LMWG	able	to	directly	interact	with	heparin,	



























































4.	 Orthogonal	 Self-Assembly	 of	 DBS-CONHNH2	 Hydrogels	 with	 C16-DAPMA	 and	
Heparin	......................................................................................................................	147	
4.1.	 Introduction	......................................................................................................	147	
4.2.	 Synthesis	 of	 DBS-CONHNH2	 Gelator	 and	 Temperature	 Induced	 Hydrogelation
	 148	
















































Figure	 1.3.	 AuNPs	 with	 high	 grafting	 density	 interact	 primarily	 through	 solvophobic	
interactions	between	polymer	coatings,	favouring	the	formation	of	planar	assemblies	(2D	




Figure	 1.5.	 Representation	 of	 the	 hierarchical	 self-assembly	 of	 a	 supramolecular	 gel.	
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the	 two	 units);	 1.3)	 Melamine	 (M),	 6,7-dimethoxy-2,4[1H,3H]-	 quinazolinedione	 (Q),	
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Figure	 1.18.	 a)	 Molecular	 structures	 of	 naphthalene-based	 LMWGs	 1.18	 and	 1.19.	 b)	
Schematic	representation	of	partial	co-assembly	of	a	mixture	of	the	LMWG	1.18	(blue)	and	





phenylalalanyl-amidoquinoline	 moiety	 (OG2)	 (top)	 and	 cryo-transmission	 electron	
microscopy	(cryo-TEM)	images	of	stable	dioleoylphosphocholine	(DOPC)	vesicles	coexisting	
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and	DOPC	 vesicles	 deformed	by	 the	 growth	 of	 the	OG2	 gel	 nanofibers	 directly	 in	 their	
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bind	 to	 GF	 receptors	 on	 the	 surface	 of	 the	 cell,	 initiating	 the	 signalling	 which	 will	 be	
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Figure	 2.2.	 Fluorescence	 intensity	 of	Nile	 Red	 (2.5	mM	 in	 PBS,	 pH	7.4)	 at	 635	nm	with	
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Figure	2.13.	 TEM	 images	of	C14-DAPMA	 (left,	 scale	bar:	200	nm)	and	C14-DAPMA	with	
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as	 green	 and	blue	 isosurfaces,	 respectively.	Hydrophilic	moieties	 of	 each	 aggregate	 are	
shown	as	white	sticks,	while	heparin	molecules	are	shown	as	orange	rods.	A	continuous	
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DBS-COOH	 gel	 with	 agarose	 ()	 and	 DBS-COOH	 gel	 with	 agarose	 and	 heparin	 (r).	
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Figure	 3.38.	 Fluorescence	microscopy	 images	 of	 cell	 in	DBS-COOH	hydrogels	with	 1330	
µg/mL	heparin	at	day	1	(left)	and	5	(right).	Magnifcation:	20x.	.......................................	137	















Figure	 3.44.	 Fluorescence	microscopy	 images	 of	 cell	 in	DBS-COOH	hydrogels	with	 1330	
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Figure	 4.37.	 Fluorescence	 microscopy	 images	 of	 mitotraker/hoechst	 staining	 of	 DBS-
CONHNH2	hydrogels,	DBS-CONHNH2	hydrogels	in	the	presence	of	heparin	(667	µg/mL	and	
1330	 µg/mL)	 and	 controls	 (medium	 with	 cells),	 with	 cells	 on	 top,	 at	 day	 1	 and	 5.	
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(right	 -	 cells	 added	directly	 into	 the	well	 and	attached	 to	 the	bottom	of	 the	well)	 after	
washing	the	membrane	with	trypsin,	on	day	7.	...............................................................	186	








Figure	 4.45.	 Optical	microscopy	 images	 of	 DBS-CONHNH2	 hydrogels	 in	 the	 presence	 of	
heparin	 (50	 µg/mL,	 25	 µg/mL	 and	 10	 µg/mL)	 and	 controls	 (medium	 with	 cells),	 in	
transwells,	at	day	1,	3	and	7.	Magnifcation:	20x.	.............................................................	189	
Figure	4.46.	Optical	microscopy	images	of	agarose	hydrogels,	DBS-CONHNH2	and	agarose	
hybrid	 hydrogels	 and	 DBS-CONHNH2	 and	 agarose	 hybrid	 hydrogels	 in	 the	 presence	 of	








hydrogels	 (0.4%	w/v)	and	controls	 (medium	with	cells),	 in	 transwells,	at	day	1,	3	and	7.	
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Figure	4.50.	Fluorescence	microscopy	images	of	calcein-AM/PI	staining	of	DBS-CONHNH2	
hydrogels	 in	 the	presence	of	heparin	 (50	µg/mL,	25	µg/mL	and	10	µg/mL)	and	controls	
(medium	with	cells),	in	transwells,	at	day	1,	3	and	7.	Magnification:	20x.	......................	193	




Figure	 4.52.	 Fluorescence	 microscopy	 images	 of	 mitotraker/hoechst	 staining	 of	 DBS-
CONHNH2	hydrogels	(0.4%	w/v)	and	controls	(medium	with	cells),	in	transwells,	at	day	1,	3	
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controls	(medium	with	cells),	in	transwells,	at	day	1,	3	and	7.	Magnification:	40x.	........	195	






Figure	 4.55.	 Absorbance	 of	 WST-1	 reagent	 at	 440	 nm	 with	 (from	 left	 to	 right):	 DBS-
CONHNH2	hydrogels;	DBS-CONHNH2	hydrogels	 in	the	presence	of	heparin	 (50	µg/mL,	25	





Figure	 4.56.	 Absorbance	 of	 WST-1	 reagent	 at	 440	 nm	 with	 (from	 left	 to	 right):	 DBS-
CONHNH2	hydrogels;	DBS-CONHNH2	hydrogels	in	the	presence	of	heparin	(667	µg/mL	and	
1330	µg/mL)	and	control	(medium	with	cells),	in	transwells,	at	day	1,	5	and	7.	.............	198	
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Supramolecular	 chemistry	 studies	 the	 noncovalent	 interactions	 between	 molecular	
building	 blocks	 which	 generate	 different	 self-assembled	 materials	 in	 different	
dimensions.1,2	Back	 in	the	1990s,	Lehn	as	described	 it	as	 ‘the	designed	chemistry	of	the	
intermolecular	 bond’.3	 These	 intermolecular	 bonds	 include	 solvophobic	 effects,	
electrostatic	 interactions,	 hydrogen	 bonding,	 p-p	 interactions	 and	 van	 der	 Waals	
interactions.	Despite	non-covalent	 interactions	being	weaker	than	covalent	 interactions,	
they	 give	 supramolecular	 materials	 unique	 properties,	 such	 as	 mechanical	 tunability,	
responsiveness	 and	directionality,	 allowing	 control	 over	 composition	 and	 functionality.4	
Additionally,	supramolecular	materials	can	play	an	important	role	in	mimicking	biological	
systems,	 as	 supramolecular	 assemblies	 are	naturally	 present	 in	 biological	 systems	 from	
bilayer	membranes	to	ribosomes	and	self-assembly	of	 lipids	 in	the	formation	of	the	cell	
membrane.	 The	 replacement	 of	 natural	 materials	 with	 biocompatible	 supramolecular	
scaffolds	 can	 be	 particularly	 useful	 for	 tissue	 engineering	 and	 in	 fact	 supramolecular	
materials	can	be	used,	for	example,	in	the	replication	of	the	structure	of	collagen	(the	main	







interactions,	 forming	 a	 stable	 host-guest	 complex	 based	 on	 the	 interactions	 between	














Self-assembly	 refers	 to	 the	 spontaneous	 association	 of	 molecules	 under	 equilibrium	
conditions	into	stable,	structurally	well-defined,	aggregates	held	together	by	non-covalent	
bonds.11	 Self-assembly	 processes	 are	 vital	 in	 nature	 and	 the	 use	 of	weak	 non-covalent	




helix.13,14	 The	 two	 single	 strands	 come	 together	 by	 hydrogen	bonding	 and	p-p	 stacking	
interactions	 between	 complementary	 nucleobases	 of	 each	 strand.	 Assembly	 and	
disassembly	 allows	 the	 structure	 to	 correct	 any	matching	 errors	 and	 to	 form	 the	most	
thermodynamically	stable	structure.			
	
The	most	 common	molecular	 structure	 used	 in	 self-assembled	 systems	 corresponds	 to	







more	 than	 compensates	 the	 entropic	 cost	 associated	 with	 the	 aggregation	 of	 the	




with	 the	 relative	 sizes	 of	 the	 hydrophobic	 and	 hydrophilic	 components,	 in	 order	 to	
geometrically	maximise	packing	and	minimise	unfavourable	solvent	interactions,	resulting	
in	 different	 geometries	 (Figure	 1.2).	 When	 hydrophilic	 heads	 are	 larger	 than	 the	
hydrophobic	tails,	this	favours	the	formation	of	spherical	micelles.	As	the	hydrophilic	heads	
become	 smaller	 in	 comparison	 to	 the	 hydrophobic	 tails,	 self-assembly	 into	 cylindrical	
shapes	is	favoured.	With	a	further	increase	in	hydrophobicity,	usually	by	the	addition	of	a	



















the	 copolymers	 affected	 the	 hierarchical	 self-assembly.	 While	 high	 copolymer	 density	




through	solvophobic	 interactions	 that	 favoured	 the	 formation	of	2D	assemblies.	On	 the	
other	hand,	AuNPs	with	 low	grafting	density	were	primarily	 interacting	through	van	der	
Waals	 interactions	which	 favoured	 the	 formation	 of	 1D	 strings.	 The	 different	 forms	 of	
assembly	resulted	in	an	important	shift	in	the	absorbance	of	the	AuNPs	from	visible	(AuNPs	








































small	molecules	 are	 usually	 called	 low-molecular-weight	 gelators	 (LMWGs),	 which	 self-
assemble	 into	 1D	 fibers	 by	 noncovalent	 interactions,	 such	 as	 hydrogen	 bonds,	 van	 der	
Waals	forces,	π-π	stacking	interactions	and	solvophobic	interactions,	into	a	3D	entangled	
network,	 preventing	 the	 flow	 of	 bulk	 solvent	 (Figure	 1.5).20,29–32	 According	 to	 the	
composition	of	 the	 liquid	phase,	supramolecular	gels	are	organogels	 (if	 the	gelator	self-
assembles	in	an	organic	solvent)	or	hydrogels	(if	the	gelator	self-assembles	in	water).	In	the	
present	 work	 hydrogels	 are	 of	 great	 interest	 as	 they	 are	 usually	 biocompatible,	 non-




most	 basic	 elements,	 supramolecular	 gels	 are	 composed	 by	 ‘zero-dimensional’	 (0D)	
building	blocks	which	undergo	nucleation	to	form	a	stable	nucleus,	prior	to	self-assembly	
to	 form	 1D	 nanofibers	 and	 subsequent	 noncovalent	 cross-linking	 to	 form	 the	 3D	
network.37,38	Supramolecular	gels	are	characterised	by	unique	properties	such	as	critical	
gelation	temperatures	(Tgel),	referring	to	the	temperature	at	which	gel-sol	transition	occurs,	
and	 the	 critical	 gelation	 concentration	 (CGC)	 which	 refers	 to	 the	minimum	 amount	 of	
gelator	required	to	form	a	gel	in	a	certain	solvent.	Almost	all	supramolecular	gels	present	



























useful	 for	 applications	 that	 require	 injectability	 and	 therefore,	 highly	 desirable	 in	 the	
biomedical	field.41,42	A	thixotropic	cholesterol-based	organogel	has	been	reported	by	Xue	
et	al.43	(Figure	1.6	–	Gelator	1.2)	where	it	was	demonstrated	that	the	LMWG	formed	stable	





































The	 examples	 described	 above	 are	 among	 a	 vast	 variety	 of	 LMWGs	 that	 form	 stimuli-
responsive	 supramolecular	 gels,	 involving	 also	 different	 types	 of	 stimuli	 such	 as	 redox	
reactions,47	 enzymes,48	metals	 and	anions49.	 Stimuli	 responsive	 supramolecular	 gels	 are	
very	 attractive	 due	 to	 their	 potential	 applications	 in	 a	 different	 range	 of	 fields.	 In	 the	
present	work,	we	are	particularly	interest	in	LMWGs	that	are	able	to	form	supramolecular	






























The	 fact	 that	 supramolecular	 hydrogels	 are	 mainly	 discovered	 by	 serendipity	 makes	 it	
complicated	 to	 predict	 which	 molecules	 will	 self-assemble	 in	 water	 only	 based	 on	
molecular	 structure.	 However,	 they	 share	 some	 properties	 such	 as	 self-assembly	 by	
noncovalent	 interactions,	 as	 already	 described	 and	 the	 presence	 of	 amphiphilicity	 that	
allows	an	effective	bottom-up	fabrication	of	the	3D	gel	network	and	provides	the	balanced	
solubility	required	for	both	gelator	aggregation	and	compatibility	with	solvent.	Therefore,	




architectures	 such	 as	 b-sheets	 and	 a-helices	 in	 solution	 and	 to	 form	 gels	 under	
physiological	 conditions,	 while	 being	 biocompatible	 and	 biodegradable.	 Peptide	
amphiphiles	(PAs)	consist	of	a	hydrophobic	region,	usually	an	alkyl	chain,	and	a	hydrophilic	
peptide	 sequence,	 with	 features	 of	 amphiphilic	 surfactants	 and	 functions	 of	 bioactive	























Stupp	 and	 coworkers	 have	 introduced	 a	 family	 of	 cationic	 PAs	 able	 to	 gelate	 water,	
consisting	of	a	hydrophobic	alkyl	chain	contributing	to	the	strongly	amphiphilic	nature	of	
the	molecule,	 followed	by	 a	 short	 peptide	 sequence	 capable	 of	 forming	 intermolecular	
hydrogen	bonding,	typically	composed	by	hydrophobic	amino	acids,	that	leads	to	1D	self-
assembly.	 Additionally,	 charged	 amino	 acids	 are	 incorporated	 into	 the	 PA	 design,	



































Adams	 et	 al.67	 concluded	 that	 the	 final	 pH	 of	 the	 Fmoc-FF	 hydrogels	 dictated	 the	
mechanical	properties	of	the	hydrogel,	due	to	the	presence	of	the	C-terminal	carboxylic	
group.	 Adams	 and	 coworkers68	 also	 studied	 the	 contribution	 of	 different	 parts	 of	
naphthalene-conjugated	 dipeptide	 to	 the	 overall	 structural	 architecture,	 by	 testing	





























urea	group	 is	at	 the	para	position	of	 the	pyridine	 it	hydrogelates,	whereas	at	 the	meta	
position	 is	 does	 not.	 This	 is	 thought	 to	 be	 due	 to	 the	 intramolecular	 CH-O	 interactions	
coupled	to	the	good	hydrogen	bond	acceptor	of	the	pyridinyl	nitrogen	atom	when	the	urea	
group	is	in	the	meta	position	making	it	a	poor	gelator	as	it	cannot	form	the	typical	urea	
tape	 motif	 responsible	 for	 one-dimensional	 fibre	 growth.74	 Different	 urea-based	




act	 as	 and	 effective	 gelator.77	 van	 Esch	 et	 al	 introduced	 a	 new	 class	 of	 effective	
hydrogelators	 based	 on	 the	 modification	 of	 the	 substituents	 of	 cyclohexane	 bis-urea	
organogelators	with	hydrophilic	hydroxy	or	 amino	 functionalities	 (Figure	1.12	–	Gelator	
1.13).	The	hydrogels	consist	of	a	network	of	fibers,	where	the	urea	groups	were	involved	
in	 intermolecular	 hydrogen	 bonding	 and	 the	 gelation	 was	 driven	 by	 hydrophobic	










An	 alternative	 type	 of	 hydrogelator	 uses	 saccharide	 groups	 instead	 of	 urea	 to	 provide	
hydrogen	interactions,	as	the	multiple	hydroxyl	groups	contribute	to	the	presence	of	both	











acidic	 environments.	 In	 another	 approach,	 Mishra	 and	 coworkers81	 demonstrated	 a	
glucose-based	 gelator	 able	 to	 effectively	 form	 thermoreversible	 hydrogels	 at	 a	 CGC	 of	
0.03%	wt/vol	in	a	mixture	of	water	and	methanol	(50:50).	The	amphiphilic	gelator	design	
was	based	on	a	hydrophilic	glucose	head	connected	through	a	triazole	incorporated	linker	
to	 the	 benzene	 ring	with	 a	 hydrophobic	 hydrocarbon	 tail	 (Figure	 1.13	 –	 Gelator	 1.15).	
Intermicellar	 aggregation	 led	 to	 the	 formation	 of	 larger	 micellar	 structures	 and	 the	
interaction	of	larger	aggregates	to	form	sheet-like	spongy	gel	networks	which	entrap	the	













2,4(3,4-dichlorobenzylidene)-D-sorbitol	 (Figure	 1.14	 –	Gelator	 1.16)	was	 studied.	 It	was	
demonstrated	that	the	addition	of	NaCl	affected	the	morphology	of	the	gels	changing	from	
globular	 aggregates	 to	 entangled	 long	 fibers.	 The	 presence	 of	 salt	 also	 contributed	 to	
slightly	 weaker	 hydrogen	 bonding	 interactions,	 probably	 due	 to	 the	 fact	 that	 the	 self-
assembly	of	the	hydrogelator	was	not	only	governed	by	 intermolecular	hydrogen	bonds	



























constituted	by	bundles	of	 fibers	and	to	be	weaker	 than	the	 transparent	gels,	which	are	
more	likely	to	form	in	higher-polarity	solvents.	Besides	the	importance	of	the	polarity	of	
the	 solvent,	 their	 ability	 to	 accept	 or	 donate	 a	 hydrogen	 bond	 appeared	 to	 be	 very	
important	to	determine	whether	the	addition	of	DBS	will	result	in	a	solution,	clear	gel,	or	








The	presence	of	 aromatic	 rings	 introduces	hydrophobicity	 into	 the	molecule	which	 is	 a	
drawback	in	terms	of	the	formation	of	hydrogels.	In	order	to	overcome	this	problem,	our	
research	group	developed	DBS	derivatives	in	which	the	aromatic	rings	are	para	substituted.	
When	 substituted	 by	 carboxylic	 acid	 groups	 (Figure	 1.16–	 a),	 the	 hydrophilicity	 of	 the	
















materials	 with	 complexity,	 containing	 independent	 functionalities,	 potentially	 able	 to	
mimic	multi-component	natural	systems.89–91	Multi-component	LMWGs	can	be	achieved	
using	 different	 approaches	 such	 as	 through	 mixing	 of	 different	 LMWGs,92–96	 or	 the	
combination	of	LMWGs	with	polymers,87,97–99	where	both	molecules	can	form	gels;	mixing	



























to	 decrease,	 there	 was	 a	 different	 rate	 of	 assembly	 and	 as	 LMWG	 1.19	 was	 not	 fully	
incorporated	it	formed	an	independent	network,	thus	self-sorting.	It	was	believed	that	the	















combination	 with	 polymer	 gels	 is	 of	 increasing	 recent	 interest	 due	 to	 the	 enhanced	










































architecture	 involving	 a	 1,3,5-cyclohexyltricarboxamide	 based	 hydrogelator	 (OG2)	 and	

















pH	 value,	 the	 encapsulation	 of	 free	 OG2	monomers	 in	 unilamellar	 liposomes	 could	 be	
achieved	at	pH	2.	The	self-assembly	of	OG2	into	nanofibers	was	then	induced	by	increasing	
the	 pH	 to	 neutral.	 As	 a	 result,	 OG2	 nanofibers	 were	 observed	 within	 the	 aqueous	
compartment	of	the	unilamellar	vesicles,	with	the	growth	of	the	fibers	restricted	by	the	
membrane	wall,	and	its	anisotropic	growth	and	rigidity	deforming	the	spherical	shape	of	








ions	 to	 Ag2	 clusters.	 The	 fusion	 of	 silver	 clusters	 into	 larger	 nanoparticles	 was	 then	




hydrogel	 based	 on	 the	 pH-stable	 hydrogelator	 DBS-CONHNH2	 which	 extracts	 precious	

















The	 controlled	 release	of	 pharmaceutical	 drugs	 requires	 the	development	of	 optimized	
systems	 that	 will	 ensure	 biodegradability;	 the	 absence	 of	 side	 effects;	 drug	 loading	
capacity;	 control	 on	 drug	 release	 kinetics;	 and	 maintenance	 of	 the	 physical-chemical	
properties	 of	 the	 drug.109,110	 Biomaterials	 with	 nanoscale	 organisation	 have	 been	
successfully	used	as	controlled	release	vehicles	for	drug	delivery.	Promising	nanoscale	drug	




Soft	materials	 such	as	hydrogels,	 can	 serve	as	 carriers	of	encapsulated	drugs	or	 can	be	
covalently	conjugated	with	therapeutics,	and	for	that	reason	have	been	widely	studied	to	





substances,	 but	 the	 encapsulation	 of	 small	 substances	 in	 hydrogels	with	 low	polymeric	













pH,	 temperature,	 etc.	 can	 be	 used	 to	 obtain	 a	 controlled	 release	 profile	 of	 bioactive	
molecules.	 In	 one	 example,	 Hamachi	 et	 al.	 have	 reported	 a	 multi-stimulus	 responsive	
phosphate-based	hydrogelator	which	responds	to	four	different	stimuli	(temperature,	pH,	
Ca2+	 and	 light)	 (Figure	 1.22).	 By	 using	 the	 multi-stimulus	 responsiveness,	 they	 formed	
supramolecular	hydrogels	in	the	presence	of	various	combinations	of	the	stimuli	and	found	
that	they	were	able	to	hold	and	release	bioactive	substances	(vitamin	B2	and	protein	Rh-





















Adams	 et	 al.122	 showed	 two	 Fmoc-aminoacid	 based	 hydrogels	 (Figure	 1.23)	 formed	 by	
adjusting	pH,	 that	were	able	 to	entrap	and	 release	model	dyes	and	may	be	 suitable	as	
controlled	 release	 systems.	 The	 release	 profiles	 showed	 typical	 sustained	 release	
behaviour	 and	 when	 plotting	 the	 released	 amount	 against	 the	 square	 root	 of	 time	 it	
indicated	 that	 the	 release	of	 dyes	 from	 the	hydrogels	was	under	 the	 control	 of	 Fickian	






















the	 aldehyde.	 Additionally,	 the	 hydrogels	 proved	 to	 effectively	 entrap	 dyes	 and	 non-
steroidal	anti-inflammatory	drugs,	followed	by	their	controlled	release	in	response	to	the	
presence	of	 specific	aldehydes.	 It	was	 reasoned	 that	because	 the	hydrogelator	 is	highly	















entrapped	 within	 the	 gel	 network	 during	 cation-based	 assembly	 and	 crosslinking.	 The	
hydrogels	were	mechanically	strong	enough	to	be	manipulated	and	placed	on	top	of	CN	at	
the	time	of	surgery.	CN	preservation	and	regeneration	were	enhanced	as	the	SHH	protein	









Fatouros	 et	 al.	 reported	 the	 design	 of	 amphiphilic	 self-assembling	 lipid-like	 peptides	
consisting	of	six	hydrophobic	alanines	(A)	and	an	aspartic	acid	(D)	or	lysine	(K)	hydrophilic	
head	group	(such	as,	Acetyl-A6K-CONH2	or	Acetyl-A6D-COOH).	These	 lipid-based	systems	
formed	turbid	suspensions	when	added	to	water	as	a	 result	of	 the	self-assembly	of	 the	
peptide	monomers	 to	minimise	 the	 interaction	between	hydrophobic	 domains	 and	 the	
polar	environment.	By	altering	the	amino	acid	sequence	and	the	charge	distribution,	the	
group	was	 able	 to	 obtain	 different	 loading	 capacities	 and	 drug	 release	 kinetics.	 Of	 the	
tested	nanovesicle	systems,	Acetyl-A6D-COOH	proved	to	be	more	suitable	for	drug	delivery.	
Negatively	 charged	 drug	 carriers	 are	 preferable	 for	 intravenous	 administration	 as	 they	
present	longer	circulation	in	the	bloodstream	due	to	electrostatic	repulsions	with	charged	











(Figure	 1.26	 -	 b).130	 Specifically,	 when	 coupling	 the	 cationic	 polar	 head	 groups	 and	































to	 certain	 stimuli	 and	 varied	 rigidity,	 being	 widely	 exploited	 to	 develop	 efficient	 3D	
scaffolds	for	cell-culture	applications.138–151	Polymer	hydrogels	are	very	widely	exploited	in	
this	 regard	 but	 supramolecular	 gels	 have	 been	 less	 extensively	 investigated.	 In	 one	
example,	 Pradas	 et	 al.139	 incorporated	 a	 self-assembling	 peptide	 (SAP)	 into	 a	 porous	
elastomer	 scaffold,	 creating	 a	 hydrogel	 with	 similar	 properties	 to	 those	 of	 ECM	 and	
observed	 that	 the	 presence	 of	 the	 SAP	 in	 the	 pores	 of	 the	 scaffold	 improved	 the	












experiment	with	 no	 gel	 coating.	 This	 hydrogel	 interacts	with	 cells	 through	 electrostatic	
interactions	between	NH3+	positive	 charge	and	 the	negative	 charged	cell	membrane.	 In	
addition,	this	LMWG	attached	more	cells	than	conventional	materials	(e.g.	sodium	alginate,	
collagen,	 poly-L-lysine	 hydrochloride),	 most	 probably	 due	 to	 the	 high	 viscosity	 of	 the	
material	that	allowed	the	hydrogel	to	strongly	stick	to	the	wells	enabling	better	adhesion.	























for	 bone	 repair.	 To	 enhance	 the	 mechanical	 strength	 of	 the	 hydrogel	 without	
compromising	 its	water	content,	the	group	developed	a	hydrogel	based	on	noncovalent	
and	Diels-Alder	chemical	dual	crosslinking.	The	noncovalent	crosslinking	was	obtained	by	
the	 supramolecular	 interaction	 of	 b-cyclodextrin	 and	 adamantane,	 which	 allowed	 the	
hydrogel	 to	 be	 formed	 in	 situ	 after	 injection.	 The	 covalent	 crosslinking	 then	 occurred	
following	 the	 injection	 of	 chondroitin	 sulfate	 (ChS-F)	 and	 maleimide-terminated	
poly(ethylene	 glycol)	 (PEG-AMI)	 via	 Diels-Alder	 reaction	 to	 reinforce	 the	 network.	 The	


















stabilises	 GFs,	 enabling	 precise	 temporal	 and	 spatial	 control	 over	 their	 actions.	 Cell	



























order	 to	 mimic	 the	 3D	 extracellular	 environment	 that	 exists	 in	 vivo	 and	 incorporated	
vascular	 endothelial	 growth	 factor	 (VEGF)	 in	 the	 presence	 of	 human	 umbilical	 vein	
endothelial	cells	(HUVEC).	Variations	of	the	composition	of	the	hydrogel	surrounding	the	




In	 the	 field	 of	 supramolecular	 materials,	 	 Stupp	 and	 coworkers171	 investigated	 how	






the	 intercalation	of	weak,	positively	charged	PA	nanostructures	 into	 the	cell	membrane	
increases	 the	 lipid	 raft	 mobility,	 which	 results	 in	 the	 enhancement	 of	 cell	 signalling.	
Therefore,	 by	 simply	 altering	 the	 nature	 of	 the	 supramolecular	 PA	 hydrogen-bond	
interactions	it	was	possible	to	potentiate	cell	signalling	by	GFs.		
	
Hartgerink	 and	 coworkers172	 reported	 the	 orthogonal	 self-assembly	 of	 multidomain	





responses	 after	 being	 injected	 subcutaneously	 in	 rats.	 When	 PlGF-1	 was	 incorporated	
directly	in	the	hydrogel	network	it	contributed	to	an	early	and	fast	release	of	the	GFs	which	
led	to	an	immature	signalling	and	low	vessel	development	in	the	short	term.	On	the	other	
hand,	 when	 incorporated	 in	 the	 liposomes,	 PlGF-1	 release	 was	 delayed	 up	 to	 3	 days,	
allowing	high	levels	of	cellular	infiltration,	followed	by	the	formation	of	blood	vessels	when	
















due	 to	 the	 need	 for	 nutrients	 and	 oxygen	 for	 the	 growth	 of	 tissue	 and	 cell	 survival.173	






25000	 Da.	 This	 polyanionic	 polysaccharide	 is	 polydisperse	 but	 is	 typically	 formed	 by	
repeated	units	of	uronic	acid	and	glucosamine	residues	and	owes	its	high	negative	charge	
to	 the	presence	of	 sulfate	 and	 carboxylic	 acid	 groups	 in	 its	 structure	 (Figure	1.32).	 The	
understanding	of	heparin	structure	has	allowed	the	development	of	low-molecular-weight	












Heparin	 interacts	with	 a	 vast	 number	 of	 proteins,	 such	 as	 proteases,	GFs,	 chemokines,	
lipoproteins	and	adhesion	proteins,	at	the	cell	surface	and	in	the	ECM.	Being	widely	known	
for	 its	 anticoagulant	 effect,183	 heparin	 has	 also	 generated	 special	 attention	 due	 to	 its	
interactions	 with	 GFs	 which	 are	 known	 to	 form	 stable	 complexes	 that	 regulate	 the	




most	 obvious	 and	 common	 interaction	 between	 them	 is	 electrostatic,	where	 positively	
charged	 amino	 acids	 from	 the	protein	 growth	 factors	will	 interact	with	 the	 sulfate	 and	
carboxylate	 groups	 in	 heparin.180,189	 Figure	 1.33	 represents	 the	 2:2:1	 fibroblast	 growth	
factor	 receptor	 (FGFR)-FGF-heparin	 complex.	 To	 initiate	 signal	 transduction,	 the	 three	
compounds	 FGF,	 FGFR	 and	 heparin	 need	 to	 interact	 simultaneously.	 In	 this	 particular	
example,	 the	complex	assembles	around	a	heparin	chain	that	 is	bound	to	two	FGF.	The	
FGF-heparin	 complex	 then	 acts	 as	 a	 bridge	 between	 the	 two	 FGFR.	 Heparin	 plays	 an	














Several	 studies	 have	 reported	 the	 use	 of	 heparin	 bound	 to	 growth	 factors	 in	 diverse	
systems,	for	controlled	delivery	into	cell	cultures	and	subsequent	controlled	release	of	the	
growth	factors,	to	promote	cell	growth.191–195	For	instance,	d’Angelo	et	al.196	described	the	
influence	 of	 heparin	 on	 VEGF	 stability	 and	 bioactivity,	 and	 its	 ability	 to	 modulate	 the	
interaction	between	growth	factors	and	ECM.	The	fact	that	the	heparin-binding	domain	is	
localised	close	to	the	VEGF	receptor-binding,	allows	heparin	to	form	a	complex	with	VEGF,	





closure	 rate	when	compared	 to	controls.	Zhao	et	al.191	developed	a	polyion	complex	 in	
which	 a	 cationic	 polymer	 bound	 electrostatically	 to	 heparin	 in	 order	 to	 enable	 the	
controlled	release	of	heparin	 into	cell	cultures	 in	the	presence	of	growth	factors.	 It	was	







delivery	 and	heparin-binding	 drug	 uptake	 into	 cells.	Niu	 et	 al.198	 disclosed	 the	 use	 of	 a	
heparin-modified	gelatin	 scaffold	 for	 transplantation	of	human	corneal	endothelial	 cells	
(HCECs)	 into	 the	 anterior	 chamber	 of	 the	 eye,	 as	 an	 alternative	 for	 cadaveric	 cornea	
transplantation.	The	work	aimed	to	develop	a	transparent	and	flexible	scaffold	based	on	
gelatin,	due	to	its	high	cell	compatibility	and	biodegradability	in	vivo,	making	it	a	suitable	
medium	 to	 seed	 the	 HCECs.	 In	 order	 to	 improve	 the	 binding	 of	 growth	 factors	 that	
supported	HCEC	growth,	the	scaffolds	were	functionalized	with	heparin.	The	presence	of	




cellular	 loss.	Additionally,	 the	use	of	heparin	 to	 immobilize	VEGF	 into	 fibroblast-derived	
extracellular	matrix	(FDM)	as	a	novel	platform	for	angiogenic	growth	factor	delivery	has	
been	 reported.199	 VEGF	 bound	 effectively	 to	 heparin-modified	 FDM	 in	 2D	 and	 3D	
environments	 and	 was	 released	 in	 a	 sustained	 manner.	 The	 bioactivity	 of	 VEGF	 was	








which	 in	 turn	binds	 to	 cell	 growth	 factors	 for	 controlled	 release,	 leading	 to	 the	perfect	
environment	and	conditions	for	cell	adhesion	and	proliferation	with	the	formation	of	blood	
vessels	 that	 are	 crucial	 for	 the	 cell	 survival	 and	 to	 avoid	 rejection.200–204	 Figure	 1.34200	
shows	a	schematic	representation	of	a	PEG-heparin	hydrogel	with	the	immobilization	of	
TGF-b	 to	promote	wound	healing.	The	design	was	thought	to	be	a	way	of	obtaining	cell	
responsiveness	 and	 adhesion	 independent	 of	 the	 gel	 network	 features,	 through	
incorporation	 of	 cleavable	 linkers	 and	 peptides;	with	 the	 degradability	 of	 the	 hydrogel	


















interactions	 heparin	 is	 adsorbed	 into	 the	 large	 surface	 area	 of	 the	 nanofibers	 and	 is	
available	to	interact	with	angiogenic	GFs	and	GF	receptors	(Figure	1.35).	The	self-assembled	

















growth	 and	 angiogenesis,	 the	 incorporation	 of	 heparin	 into	 hydrogels	 could	 lead	 to	 an	
initial	burst	release	of	heparin,	being	difficult	to	control	in	a	constant	way.	In	this	sense,	the	
incorporation	of	a	heparin/	heparin	binding	molecule	complex	into	a	biocompatible	and	














































It	 is	 perhaps	 not	 surprising	 that	 numerous	 examples	 of	 supramolecular	 systems	 with	
biological	 functions	 have	 arisen	 making	 use	 of	 self-assembly	 to	 organise	 molecules	 to	
generate	 multivalent	 recognition,	 this	 is,	 through	 self-assembling	 multivalency	
(SAMul).211,212	 Typically,	 synthetic	 SAMul	 systems	 are	 achieved	 by	 using	 amphiphilic	
molecules	 able	 to	 self-assemble	 in	 aqueous	 solutions.	 These	 building	 blocks	 present	 a	
number	of	advantages	over	covalent	structures	as	they	are	usually	simple	to	synthesise,	
the	design	of	 the	 individual	binding	 ligands	can	be	tuned	for	different	receptors	and	by	
changing	the	hydrophobic	tail,	different	aggregate	morphologies	can	be	obtained.	Another	
fundamental	 advantage	 is	 the	 reversibility	 of	 the	 SAMul	 systems	 that	 can	 lead	 to	
multivalent	binding	being	 switched	off	by	 triggering	disassembly,	which	 can	 reduce	 the	
toxicity	of	bioactive	SAMul	nanostructures	and	improve	specificity.	As	an	example,	Smith	
and	 co-workers	 compared	 the	 binding	 affinity	 of	 different	 amphiphilic	 molecules	
containing	a	hydrophilic	arginine-glycine-aspartic	acid	(RGD)	ligand	group.	RGD	tripeptides	
were	chosen	to	provide	 the	system	with	 integrinii	binding	ability	and	a	comparison	was	
performed	 between	 a	 large	 covalent	 RGD	 multivalent	 binder,	 the	 equivalent	 self-
assembled	 monomer	 and	 an	 analogous	 non-assembled	 monomer	 (Figure	 1.37).	 It	 was	
concluded	 that	 the	self-assembling	system	demonstrated	similar	 integrin	binding	 to	 the	
covalent	RGD	dendrimer,	revealing	higher	affinity	than	the	non-assembling	monomer,	due	




















The	 aim	 of	 this	 project	was	 to	 study	 the	 orthogonal	 self-assembly	 of	multi-component	
hybrid	materials	using	LMWGs	as	3D	scaffolds,	which	incorporate	bioactive	heparin	(Figure	
1.38),	gain	a	detailed	understanding	of	their	activity,	and	explore	their	potential	high-tech	
applications.	 Understanding	 these	 multi-component	 materials	 assembled	 from	 the	

































A	 good	 example	 of	 a	 self-assembling	 system	with	 high	 affinity	 to	 bind	 to	 heparin	 was	
developed	by	Smith’s	group	with	a	design	inspired	by	the	Fréchet	dendron	scaffold.219	The	
ligand	is	shown	in	Figure	2.1	and	contains	peripheral	amines	that	protonate	at	physiological	
















Considering	 the	 clinical	 importance	 of	 heparin	 binding,220	 and	 with	 the	 goal	 of	
incorporating	 such	 structures	 in	 controlled	 release	 gels,	 we	 were	 interested	 in	 better	
understanding	 the	 potential	 of	 this	 type	 of	 SAMul	 nanostructure.	 To	 this	 purpose,	 this	
chapter	will	focus	on	the	study	of	simple	cationic	SAMul	heparin	binders	in	order	to	achieve	
a	 detailed	 characterisation	 in	 terms	 of	 structure,	 hydrophobic	 region	 influence	 in	 self-
assembly	and	heparin	binding	and	hierarchical	assembly	processes.	In	particular,	we	aimed	
to	go	beyond	our	previous	research	by	synthesising	simple	binders,	which	can	be	easily	
made	 at	 scale	 and	 incorporated	 into	 gels.	Ultimately,	 the	most	 efficient	 system	will	 be	






















The	 coupling	 between	 tert-butyl	 3-((3-aminopropyl)(methyl)amino)propyl	 carbamate	
(protected	DAPMA)	and	 the	 fatty	 acids	was	performed	using	a	highly	efficient	 coupling	
agent	 2-[(1H-Benzotriazole-1-yl)-1,1,3,3-	 tetramethyluroniumtetrafluoroborate]	 (TBTU).	


























amphiphilic	 molecules.	 Nile	 Red	 is	 a	 hydrophobic	 dye	 highly	 dependent	 on	 the	







fluorescent	 hydrophobic	 probe	 to	 identify	 the	 aggregation	of	 amphiphilic	molecules.	 In	





















































The	 calculated	 CMC	 values	 are	 shown	 in	 Table	 2.1.	 As	 expected,	 C14-DAPMA	 has	 the	
highest	CMC	value	because	it	has	the	smallest	hydrophobic	chain	and	therefore	the	lowest	




























































Mallard	 Blue	 (MalB)	 assays	 were	 then	 performed	 in	 order	 to	 test	 the	 heparin	 binding	
effectiveness	of	each	system.	Mallard	Blue	is	a	cationic	dye	developed	by	the	Smith	group	





complex	with	heparin	by	 the	 interaction	of	heparin	with	another	molecule,	 this	 can	be	
easily	 verified	 by	 an	 increase	 in	 the	MalB	 absorbance.	 An	 assay	 is	 then	 performed	 by	
increasing	the	concentration	of	binder	and	monitoring	MalB	by	UV-Vis.				
	
Figures	 2.5,	 2.6	 and	 2.7	 confirm	 the	 gradual	 displacement	 of	MalB	with	 the	 increasing	



























































































































































































Sample	 CE50	 EC50	/	µM	 Dose	/	mg	100	IU-1	
C14-DAPMA	 0.88	±	0.05	 48	±	3	 0.59	±	0.03	
C16-DAPMA	 0.64	±	0.02	 34	±	1	 0.46	±	0.01	












DLS	 is	 a	 technique	 that	 measures	 the	 time-dependent	 fluctuations	 in	 the	 intensity	 of	
scattered	light	that	occur	because	particles	undergo	Brownian	motion.229	The	analysis	of	
these	 intensity	 fluctuations	 can	 determine	 the	 diffusion	 coefficients,	 which	 can	 be	
converted	into	a	size	distribution	using	the	Stokes-Einstein	equation:	
	 𝑅- = 	 𝐾𝑇6𝜋𝜂𝐷	
	
where	 RH	 is	 the	 hydrodynamic	 radius,	 D	 the	 diffusion	 coefficient,	 K	 is	 the	 Boltzmann’s	












on	 the	 mass	 or	 volume	 of	 the	 particles	 instead	 of	 scattered	 light)	 to	 have	 a	 better	



























to	 confirm	 that	 this	 is	 the	 size	 difference	 observed.	 On	 the	 other	 hand,	 C18-DAPMA	
revealed	the	presence	of	significantly	large	aggregates	(ca.	100	nm).	As	the	self-assembled	
micelles	were	 expected	 to	 have	 smaller	 sizes	 and	 C18-DAPMA	 has	 poor	 solubility,	 it	 is	



























When	 the	 binders	 were	 in	 the	 presence	 of	 heparin	 a	 significant	 increase	 of	 the	 size	
distribution	was	 observed	 (at	 2:1	 binder:heparin	 charge	 ratio).	 The	 presence	 of	 a	 very	
broad	and	large	population	when	the	binders	are	in	the	presence	of	heparin	suggests	the	
formation	 of	 agglomerates	 between	 them,	 providing	 evidence	 of	 the	 existence	 of	
hierarchical	interactions	between	the	binders	and	heparin	(see	TEM	images	in	the	following	










approach	 makes	 the	 assumption	 that	 the	 species	 under	 investigation	 are	 spherical	 in	
morphology.		
	
Furthermore,	on	binding	 to	heparin,	 the	zeta	potential	decreased,	as	a	 result	of	 charge	
neutralisation	induced	by	heparin	binding	–	the	charge	neutralisation	was	greatest	for	the	
least	effective	binder	C14-DAPMA,	while	the	most	effective	binder	C16-DAPMA,	showed	
the	 lowest	 extent	 of	 charge	 neutralisation	 –	 in	 line	 with	 the	 view	 that	 C16-DAPMA	 is	
actually	very	efficient	in	using	its	positive	charge	to	bind	to	the	fixed	amount	of	heparin	
present.	 DLS	 therefore	 suggests	 a	 degree	 of	 nanoscale	 aggregation	 between	 the	
polycationic	self-assembled	micelles	and	heparin	polyanions.	The	evolution	of	hierarchical	




















reorganisation,	 even	 in	 the	presence	of	 heparin,	with	which	 they	 can	 form	 very	 strong	
electrostatic	interactions,	and	an	effective	2D	‘ionic	lattice’	on	the	TEM	grid.			
	































































The	 nanostructure	 of	 the	 aqueous	 binder-heparin	 complex	 was	 then	 investigated	




for	 polycrystalline	 samples	 with	 isotropic	 orientation	 of	 multiple	 crystals.234	 For	 the	
assembly	formed	between	C14-DAPMA	and	heparin	the	positions	of	the	diffraction	peaks	






observed	 for	 those	 formed	 by	 C14-DAPMA,	 may	 be	 suggestive	 of	 a	 greater	 degree	 of	
nanocrystalline	order	for	the	C16-DAPMA	system	or	a	different	form	factor	for	the	micelles.	
This	 would	 be	 in	 agreement	 with	 the	 lower	 CMC	 and	 greater	 heparin	 binding	 ability	




molecular	 structures	 can	 play	 a	 directing	 role	 in	 the	 formation	 of	 nanocrystalline	
assemblies	via	electrostatic	interactions	between	polyionic	species.235–237	In	this	case,	the	
modification	 of	 lattice	 parameters	 based	 on	 the	 size	 of	 the	molecular	 scale	 surfactant	
building	 block	 is	 a	 clear	 example	 of	 the	 way	 in	 which	 molecular	 parameters	 can	 be	
translated	into	the	packing	of	hierarchical	nanocrystalline	structures.	
	
The	 quadratic	 Miller	 indices	 were	 plotted	 against	 the	 measured	 q(hkl)	 values	 for	 C14-
DAPMA-heparin	 and	 C16-DAPMA-heparin	 complexes,	 as	 shown	 in	 Figure	 2.17b	 and	 c,	








for	 the	 C14-DAPMA	 and	 6.3	 nm	 for	 the	 C16-DAPMA,	 again	 in	 line	 with	 mesoscale	
predictions.	
	
The	 centre-to-centre	 distances	 are	 also	 in	 agreement	 with	 the	 micellar	 diameters	
determined	by	DLS	methods.		It	should	be	remembered	that	as	a	solution-phase	method,	
DLS	 also	 includes	 the	 solvent	 and	 counterions	 at	 the	micellar	 periphery,	 which	will	 be	
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the	 viewpoint	 that	 the	 micellar	 objects	 have	 excellent	 structural	 integrity	 and	 can	 be	

























To	 gain	 a	 better	 understanding	 of	 how	 these	 heparin	 binders	 behave	 over	 time,	
degradation	 studies	were	 performed	using	 two	different	 approaches	 to	 study	 both	 the	
molecular	degradation	as	well	as	the	disassembly	process	of	C14-DAPMA	and	C16-DAPMA.	
In	order	to	determine	the	molecular	degradation	of	C14-DAPMA	and	C16-DAPMA,	a	mass	
spectrometry	 study	 was	 performed	 over	 time.	 Each	 binder	 was	 dissolved	 in	 buffered	
solution	at	pH	7.5	and	incubated	at	37	°C.	Gly-Ala	dipeptide	was	added	as	internal	standard	
to	 the	 binder	 solutions	 prior	 to	measurement	 and	mass	 spectra	 of	 both	 binders	 were	
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of	 degradable	 binders	 with	 ester	 linkages	 that	 are	 easily	 cleaved	 under	 physiological	
conditions.	 By	 replacing	 the	 ester	 with	 an	 amide	 linkage	 in	 the	 C14-DAPMA	 and	 C16-
























































In	 conclusion,	 three	 self-assembling	 amphiphilic	 molecules	 have	 been	 successfully	








to	 the	 most	 effective	 heparin	 binder,	 of	 this	 simple	 family	 of	 compounds.	 DLS	
measurements	 for	 the	 three	 binders	 proved	 the	 existence	 of	 larger	 aggregates	 when	
heparin	was	present	in	solution,	 indicating	once	more	the	effective	interaction	between	
the	binder	and	heparin.	Furthermore,	TEM	images	showed	highly	organised	nanocrystalline	
hierarchical	 assemblies	 when	 C14-DAPMA	 and	 C16-DAPMA	 were	 in	 the	 presence	 of	
heparin.	In	addition,	characterisation	by	mesoscale	simulations	and	SAXS	of	C14-DAPMA	










3. Orthogonal	 Self-Assembly	 of	 DBS-COOH	 Hydrogels	 with	 C16-
DAPMA	and	Heparin	
Part	of	 the	work	presented	 in	 this	 chapter	was	 carried	out	 in	 conjunction	with	MChem	
student	 Laura	 Hay	 and	 published	 in	 Chem.	 Sci.,	 2017,	 DOI:	 10.1039/C7SC03301J.	








for	 drug	 delivery	 and	 to	 promote	 cell	 adhesion,	 migration,	 differentiation	 and	





This	 way,	 multicomponent	 hydrogels	 are	 very	 promising	 nanostructures	 for	 tissue	





strength	 can	 limit	 their	 applications,	 and	 therefore	a	method	of	 improving	 this	without	
losing	the	responsive	nature	of	such	gels	can	be	achieved	by	integration	of	LMWGs	with	
PGs	 creating	 a	 hybrid	 hydrogel,	 where	 the	 mechanical	 strength	 of	 the	 gel	 is	 greatly	
enhanced.87,98,248–251	The	responsive	nature	of	hybrid	hydrogels	was	proven	when	the	pH	
responsive	 ability	 of	 a	 LMWG,	 1,3:2,4-dibenzylidene-D-sorbitol–p,p’-dicarboxylic	 acid	
(DBS–COOH),	to	assemble	and	dissemble	into	a	hydrogel	in	the	presence	of	the	PG	agarose	












Additionally,	 there	 is	 an	 interest	 in	 applying	 heparin,	 which	 has	 clinical	 use	 as	 an	
anticoagulant,182,252	for	transdermal	or	subcutaneous	low-dose	delivery	for	long	term	use	
in	hospital	settings.194,253	Heparin	has	also	been	included	in	gels	with	potential	applications	





self-assembly	 of	 the	 hydrogel	 with	 self-assembled	 C16-DAPMA	 for	 heparin	 binding	 is	
investigated.	 	Additionally,	 the	 incorporation	of	heparin	within	a	two-component	hybrid	
hydrogel	 combining	 a	 polymer	 gelator	 (agarose)	 and	 a	 LMWG	 (DBS-COOH)	 is	 studied.	





























slow	 acidification	 of	 a	 basic	 solution.	 Initially,	 NaOH	 was	 added	 in	 order	 to	 basify	 the	











The	 three	 different	 concentrations	 of	 DBS-COOH	 tested,	 resulted	 in	 the	 formation	 of	
homogeneous	gels,	as	shown	in	Figure	3.2.	However,	for	concentrations	of	0.1%	w/v	a	very	








3.3. Study	 of	 Orthogonal	 Self-Assembly	 of	 DBS-COOH	 with	 C16-DAPMA	 and	
Heparin	
The	main	aim	of	 this	project	 consists	 in	 studying	 the	 self-assembly	of	multi-component	
hydrogels	with	the	incorporation	of	a	bioactive	factor	-	heparin.	To	gain	initial	insight	into	
multi-component	 systems,	 simple	 visual	 experiments	 of	 gelation	 were	 performed.	
Therefore,	 the	 assembly	 of	 DBS-COOH	 hydrogel	 with	 C16-DAPMA	 micelles	 bound	 to	


















The	 same	 test	was	 repeated,	 but	 adding	 the	heparin-C16-DAPMA	 solution	 immediately	
after	 GdL	 or	 before	 the	 GdL	 addition.	 The	 formation	 of	 stable	 gels	 in	 both	 cases	 was	
verified,	with	a	final	pH	of	5.	Therefore,	in	a	first	analysis	it	is	possible	to	conclude	that	the	
orthogonal	 self-assembly	 of	 DBS-COOH	 hydrogels	 in	 the	 presence	 of	 heparin/heparin	
binder	complexes	is	achievable.			
	












































































because	 the	excess	C16-DAPMA	 is	not	binding	 to	heparin	 and	 thus	disrupts	 gelation	as	
observed	for	C16-DAPMA	alone.	We	note	that	as	the	concentration	of	heparin/binder	in	


























in	 DBS-COOH	 tested,	 the	 Tgel	 obtained	 was	 over	 100	 °C,	 proving	 that	 the	 presence	 of	
heparin	does	not	adversely	 impact	on	 the	 thermal	 stability	of	 the	gel.	 For	 the	different	
concentrations	of	C16-DAPMA	with	heparin	that	resulted	in	gel	formation,	the	Tgel	values	
again	all	appeared	to	be	above	100	°C,	indicating	that	the	presence	of	heparin	bound	to	

















carboxylate	peak	of	 heparin.	 Between	1400	and	1294	 cm-1	 several	 peaks	 from	 the	DBS	
sugar	are	noticeable.	At	1018	cm-1	a	strong	peak	is	verified,	probably	corresponding	to	the	










































































For	 the	 DBS-COOH	 sample,	 no	 gel	 formation	 occurred	 for	 the	 first	 hour	 and	 a	 gradual	
increase	in	the	%	gelation	takes	place	over	the	next	seven	hours,	until	all	the	molecules	are	
immobilised,	meaning	 that	 100%	 of	 the	molecules	 formed	 a	 gel	 after	 approximately	 8	
hours.	DBS-COOH	with	300	µM	of	heparin	presented	a	similar	kinetic	profile,	with	a	gradual	
increase	 in	 %	 of	 immobilised	 gelator	 over	 time,	 achieving	 100%	 gelation	 after	
approximately	9	hours.	The	sample	of	DBS-COOH,	300	µM	of	heparin	and	800	µM	of	C16-








nanoscale	 network	 of	 the	 DBS-COOH	 hydrogel,	 DBS-COOH	 hydrogel	 in	 the	 presence	 of	
heparin	and	DBS-COOH	hydrogel	 in	 the	presence	of	both	heparin	and	C16-DAPMA.	 It	 is	
noteworthy	that	this	experiment	was	performed	below	the	gelation	concentration	of	DBS-
COOH	 (0.02%	w/v),	hence	we	observe	 the	assembly	of	organised	nanofibers	within	 the	
sample	but	not	the	complete	formation	of	the	gel-phase	material.	
	
From	 the	 obtained	 data	 (Figure	 3.8),	 in	 each	 case	 the	 presence	 of	 a	 CD	 band	 at	





















the	 presence	 of	 heparin	 promotes	 the	 growth	 of	 the	 DBS-COOH	 nanofibers	 while	 the	
presence	of	C16-DAPMA-heparin	complex	appears	to	somewhat	slow	the	rate	of	growth	of	








































































verify	 that	 the	 sample	 of	 DBS-COOH	 containing	 C16-DAPMA	 and	 heparin	 resulted	 in	 a	
decrease	of	MalB	absorbance	similar	 to	 the	control.	On	the	other	hand,	when	the	DBS-













































TEM	 images	 of	 DBS-COOH	 gel,	 DBS-COOH	 gel	 in	 the	 presence	 of	 heparin,	 and	 in	 the	






and	at	a	heparin	concentration	of	38	µM	 it	was	possible	 to	distinguish	 the	existence	of	
some	 differentiated	 structures,	 particularly,	 but	 not	 exclusively	 on	 the	 tips	 of	 the	
nanofibers.	 This	may	 be	 related	 to	 the	 fact	 that	 heparin	 can	 induce	 the	 growth	 of	 the	
nanofibers,	as	already	observed	in	the	CD	studies.	It	is	known	that	in	organogels,	polymers	















and	 C16-DAPMA,	where	 the	 presence	 of	 aggregates	 along	with	 the	 nanofibers	 of	 DBS-
COOH	is	evident.	The	observed	hierarchical	aggregates	should	correspond	to	the	binding	
































SEM	 images	 obtained	 for	 DBS-COOH	 gel	 incorporating	 both	 C16-DAPMA	 and	 heparin	
(Figure	3.18),	only	revealed	the	presence	of	nanofibers	from	the	DBS-COOH	self-assembly;	
it	was	not	possible	 to	distinguish	 the	presence	of	C16-DAPMA	 interacting	with	heparin.	
Interestingly,	 however,	 the	 fibers	 were	 equivalent	 to	 those	 formed	 in	 the	 absence	 of	
heparin	which	would	suggest	that	C16-DAPMA	binds	heparin	and	prevents	its	interaction	





































the	 overall	 stability	 of	 the	 network	 perhaps	 somewhat	 limiting	 nanoscale	 chain	
entanglement	 which	 contributes	 to	 macroscopic	 behaviour	 and	 network	 formation.	
Additionally,	the	incorporation	of	heparin	and	heparin-C16-DAPMA	aggregates	within	the	
gel	 network	 resulted	 in	 a	 decrease	 of	 G’	 value	 from	 approximately	 2600	 Pa	 to	














G’	 value	 from	approximately	 2600	 Pa	 to	 approximately	 7900	 Pa,	meaning	 that	 agarose	
contributes	to	the	formation	of	a	stiffer	gel	network,	while	presenting	a	stability	similar	to	
the	DBS-COOH	hydrogel	 (LVR	approximately	3%).	 The	addition	of	heparin	 to	 the	hybrid	












































































































act	 as	 a	 vehicle	 for	 heparin	 delivery	 in	 a	 controlled	 manner	 for	 clinical	 purposes	 and	





































the	 aim	 of	 limiting	 diffusion	 of	 heparin	 out	 of	 the	 gel,	 so	 that	 release	 would	 only	 be	
achieved	 on	 breakdown	 of	 the	 DBS-COOH	 network.	 The	 same	 procedure	 as	 described	
above	was	followed.	Comparing	release	from	the	0.2%	w/v	and	2%	w/v	DBS-COOH	gels	







































heparin.	 Since	 5%	 w/v	 and	 10%	 w/v	 of	 DBS-COOH	 did	 not	 contribute	 to	 any	 further	
reduction	 in	 release	 of	 heparin	 or	 significant	 changes	 in	 initial	 release	 kinetics	 when	



































Tris-HCl/	150	mM	NaCl	buffer,	 using	 the	 same	method	as	described	above.	 Figure	3.27	
shows	 that	 as	 agarose	 concentration	 increases,	 heparin	 release	 is	 inhibited.	 With	 the	
increase	in	agarose	concentration,	a	gel	network	will	be	formed	with	smaller	pore	sizes	that	
































of	 agarose	 in	 order	 to	 test	 the	 influence	 of	 these	 hybrid	 gels	 on	 heparin	 release	when	
compared	with	DBS-COOH	hydrogels	(2%	w/v).	As	shown	in	Figure	3.28,	the	presence	of	
0.5	 or	 1%	w/v	 of	 agarose	 together	 with	 DBS-COOH	 hydrogelator	 resulted	 in	 the	 same	
heparin	release	profile	as	when	only	DBS-COOH	is	used.	 In	addition,	of	the	two	agarose	

































important	 to	note	 that	 the	addition	of	agarose	was	essential	 to	make	these	gels	 robust	







































































Prior	 to	 gelation	 the	 resonances	 corresponding	 to	 the	 aromatic	 protons	 of	 DBS-COOH	
appear	 as	 a	 duplet	 at	 7.86-7.83	 ppm	 and	 as	 a	 quartet	 at	 7.59-7.56.	 As	 the	 DBS-COOH	
molecules	 self-assemble	 into	 gel	 fibres	 they	 become	 immobile	 on	 the	 NMR	 timescale,	






















ca	4-5)	 remained	 intact,	and	so	 it	appears	 that	 this	base	 is	unable	 to	deprotonate	DBS-
COOH	on	a	suitable	timescale.	A	pH	10	buffer	(borax/NaOH)	was	trialled	but	this	was	also	
unable	to	break	down	the	DBS-COOH,	thus	future	experiments	should	seek	to	find	a	base	
















































Dulbecco’s	Modified	 Eagle’s	Medium	 (89%	 DMEM	 –	 high	


























































































































































































































































Figure	 3.45	 shows	 the	 obtained	 absorbance	 of	 formazan	 for	 DBS-COOH	 hydrogels	 in	
transwells	 assay.	 On	 day	 1,	 the	 metabolic	 activity	 of	 cells	 from	 DBS-COOH	 hydrogels	






































LMWG	 DBS-COOH	 was	 successfully	 synthesised	 and	 its	 orthogonal	 self-assembly	 with	
heparin	 and	 C16-DAPMA	 investigated.	With	 the	 addition	 of	 different	 concentrations	 of	
binder	and	heparin	to	DBS-COOH	separately,	it	was	possible	to	verify	that	heparin	did	not	
prevent	the	formation	of	DBS-COOH	gels,	in	contrast	with	the	binder,	which	significantly	
































DBS-COOH.	 The	 orthogonal	 self-assembly	 of	 DBS-COOH	 with	 both	 binder	 and	 heparin	




and	 DBS-COOH	 suggesting	 orthogonal	 assembly.	 The	 study	 of	 gel	 formation	 by	 NMR,	




nanofibers	 was	 also	 studied	 using	 CD	 and	 it	 was	 observed	 that	 heparin	 appeared	 to	
promote	the	growth	of	the	fibers	–	suggesting	that	the	nanofibers	formed	by	DBS-COOH	















Therefore,	 it	 is	possible	 to	conclude	 that	DBS-COOH	and	heparin	are	 largely	orthogonal	












can	 be	 controlled	 either	 by	 changing	 the	 surface	 area	 for	 release,	 or	 by	 altering	 the	
concentration	of	agarose	and/or	DBS-COOH,	resulting	in	a	change	of	pore	size	of	the	gel.	In	
conclusion,	 there	 is	 a	 threshold	 DBS-COOH	 network	 density	 that	 prevents	 heparin	
diffusion,	 limiting	 total	 release,	while	 agarose	has	 a	progressive	effect	on	diffusion	and	
release	of	heparin	with	higher	agarose	loadings	decreasing	heparin	release	kinetics.		NMR	
studies	 indicate	 that	 DBS-COOH	 in	 the	 presence	 of	 heparin	 and	 agarose	 is	 still	 able	 to	











replaced	 over	 the	 week	 and,	 as	 the	 gels	 dissolved,	 they	 could	 had	 been	 washed	 off,	
specially	for	the	2D	cell	culture	with	cells	on	top.	Moreover,	the	cells	used	are	very	resistant	





to	 deprotonate	 DBS-COOH	 on	 a	 suitable	 timescale,	 while	 still	 allowing	 facile	 heparin	
quantification	using	MalB.	Additionally,	the	fact	that	C16-DAPMA	is	a	very	stable	binder	













4. Orthogonal	 Self-Assembly	 of	 DBS-CONHNH2	 Hydrogels	 with	
C16-DAPMA	and	Heparin	











this	 purpose,	 this	 chapter	will	 focus	 on	 the	 properties	 of	 DBS-CONHNH2	 as	 a	 potential	
scaffold	for	cell	growth	and	the	orthogonal	self-assembly	of	the	hydrogel	with	heparin	and	
self-assembled	C16-DAPMA.	As	in	the	previous	Chapter,	the	incorporation	of	heparin	into	













4.2. Synthesis	 of	 DBS-CONHNH2	 Gelator	 and	 Temperature	 Induced	
Hydrogelation	
DBS-CONHNH2	 was	 obtained	 from	 the	 DBS-COOCH3	 derivative	 using	 a	 hydrazination260	
reaction	 as	 previously	 reported	 the	 by	 Smith	 group.88	 DBS-COOCH3	was	 synthesised	 as	
previously	 described	 in	 Chapter	 3.	 The	 reaction	 between	 DBS-COOCH3	 and	 excess	
hydrazine	monohydrate	 resulted	 in	a	white	precipitate	 that	after	 filtration	and	washing	








CONHNH2	 solution	 until	 the	 gelator	was	 completely	 dissolved	 and	 a	 clear	 solution	was	
observed,	following	by	cooling	to	room	temperature.	In	order	to	obtain	stable	and	uniform	
gels,	a	concentration	of	0.4%	w/v	of	DBS-CONHNH2	was	used.	This	concentration	of	DBS-
CONHNH2	was	 found	 to	 be	 the	maximum	 concentration	 of	 gelator	 that	 resulted	 in	 the	
formation	 of	 stable	 and	 uniform	 hydrogels.	When	 using	 higher	 concentrations	 of	 DBS-

















DBS-CONHNH2	 hydrogels	 are	 formed	 immediately	 after	 heating,	 thus	 the	 only	 way	 to	
incorporate	heparin	and	heparin-C16-DAPMA	aggregates	within	the	gel	network	was	by	
adding	 them	 to	 the	 solution	before	heating.	 Therefore,	 the	 stability	of	 the	C16-DAPMA	
micelles	at	high	 temperatures	was	 tested,	 to	understand	how	temperature	affects	C16-
DAPMA	self-assembly	and	interactions	with	heparin.		
	




the	 two	 different	 temperatures,	 indicating	 that	 heating	 does	 not	 affect	 the	 repulsion	
between	 the	 particles	 and	 the	micelles	 are	 highly	 charged	 at	 70	 °C.	Moreover,	 it	 was	
observed	that	the	increase	in	temperature	contributed	to	a	decrease	of	the	polydispersity	
index,	 indicating	 that	 at	 high	 temperatures	 the	 micelle	 population	 has	 a	 better	























Vis	 band	 decreases	 substantially	 in	 intensity.	 Therefore,	 if	 MalB	 is	 displaced	 from	 its	





























In	 order	 to	 initially	 and	 quickly	 test	 the	 influence	 of	 heparin	 on	 the	 formation	 of	 the	
hydrazide	gel,	different	concentrations	of	heparin	(38	µM;	150	µM;	300	µM;	400	µM;	600	












formation.	 Once	 more,	 for	 all	 the	 concentrations	 used,	 the	 formation	 of	 stable	 and	
homogeneous	gels	was	observed.	This	indicates	that	the	presence	of	C16-DAPMA	micelles	
does	not	 interfere	 in	the	self-assembly	of	 the	DBS-CONHNH2	gelator.	This	 is	contrary	to	






































Therefore,	 the	 incorporation	 of	 C16-DAPMA	 interacting	with	 heparin	 did	 not	 affect	 gel	
formation,	but	at	higher	heparin/C16-DAPMA	concentrations	non-uniform	or	unstable	gels	
resulted.	This	may	relate	to	the	fact	that	at	higher	heparin/C16-DAPMA	concentrations,	








































µM	 of	 heparin	 and	 1200	 µM	 of	 C16-DAPMA	 (Figure	 4.4).	 By	 comparing	 the	 obtained	
spectra,	 it	 is	 possible	 to	 observe	 that	 the	 expected	 peaks	 are	 present	 in	 the	 multi-
component	gel	and	that	the	spectrum	corresponds	to	simple	overlap	of	IR	spectra	of	the	
three	 compounds.	Additionally,	 the	 IR	 spectra	of	DBS-CONHNH2	with	heparin	 and	DBS-






















































































































































within	 the	network	 it	 becomes	more	difficult	 for	 the	MalB	 to	diffuse	 into	 the	 gel,	 thus	
resulting	 in	 a	 lower	 dilution	 and	 higher	 absorbance.	 On	 the	 other	 hand,	 when	 DBS-
CONHNH2	gel	contains	heparin	it	is	noticeable	a	higher	decrease	of	the	MalB	absorbance	



















or	C16-DAPMA	and	 in	 the	presence	of	both	heparin	and	C16-DAPMA	were	obtained,	 in	
order	to	better	understand	the	morphology	and	behaviour	of	these	four	different	systems.	
TEM	 images	 of	 DBS-CONHNH2	 gel	 (Figure	 4.11)	 showed	 the	 presence	 of	 twisted	 and	
branched	 nanofibers,	 proving	 the	 self-assembly	 of	 this	 gelator	 into	 1D	 fibers	 in	 water.	
When	 heparin	 was	 present	 within	 the	 gel	 (Figure	 4.12)	 it	 was	 possible	 to	 observe	 the	
presence	of	 the	twisted	 fibers	as	well	as	 large	unspecific	aggregates	 that	correspond	to	
heparin.	 This	 appears	 to	 indicate	 that	 there	 are	 no	 interactions	 occurring	 between	 the	
gelator	and	heparin	when	the	 former	 is	 self-assembling.	This	 is	 in	contrast	 to	what	was	
observed	with	DBS-COOH	 in	Chapter	3.	The	 incorporation	of	C16-DAPMA	 into	 the	DBS-
CONHNH2	gel	(Figure	4.13)	appears	to	have	a	similar	effect.	Once	more,	 it	 is	possible	to	
distinguish	the	presence	of	nanofibers	along	with	undefined	agglomerates	that	correspond	



























































aggregates.	 The	 observed	 aggregates	 showed	 a	 highly	 organised	 semi	 crystalline	
nanostructure	 (Figure	 4.15),	 characteristic	 of	 the	 hierarchical	 systems	 formed	 by	 C16-
DAPMA	when	 binding	 to	 heparin	 (as	 described	 in	 Chapter	 2).	 Therefore,	 the	 obtained	

















was	 also	 possible	 to	 identify	 some	 large	 and	 aligned	 structures	 (Figure	 4.16)	 that	may	






SEM	 images	of	DBS-CONHNH2	gel	 (Figure	4.17)	 showed	a	network	 structure	comprising	














micelles	are	difficult	 to	 image	using	 this	 technique.	However,	no	 interactions	appear	 to	

















SEM	 images	 of	DBS-CONHNH2	with	 both	 heparin	 and	C16-DAPMA	 incorporated	 (Figure	
4.20)	revealed	the	presence	of	gel	nanofibers	but	also	thicker	structures	(916	±	213	nm)	
that	resemble	needles.	A	closer	look	at	these	structures	showed	what	appears	to	be	a	rigid	
alignment	 of	 gel	 nanofibers.	We	 suggest	 this	 alignment	may	 be	 induced	 by	 the	 highly	
organised	hierarchical	nanostructures	 formed	when	C16-DAPMA	 interacts	with	heparin.	
























were	 obtained,	 through	 the	 application	 of	 oscillating	 strains.	 If	 the	material	 presents	 a	
higher	 G’	 than	 G’’	 with	 low	 frequency	 dependency	 it	 has	 mechanical	 properties	
characteristic	of	a	gel.256,257		
	
Figure	 4.21	 shows	 the	 strain	 amplitude	 dependence	 of	 G’	 and	 G’’	 for	 0.4%	 w/v	 DBS-
CONHNH2	gels,	where	it	is	possible	to	observe	a	LVR	up	to	approximately	1%	strain	when	
C16-DAPMA	is	incorporated	within	the	network	and	approximately	2.5%	for	all	the	other	



















































increase	 of	 G’	 from	 approximately	 3800	 Pa	 to	 15000	 Pa	 was	 observed,	 indicating	 the	
presence	of	a	much	stiffer	gel,	resulting	from	the	robustness	of	agarose.	However,	the	LVR	
only	 reaches	approximately	2%	of	 strain.	When	heparin	was	added	 to	DBS-CONHNH2	in	






























samples,	 exhibiting	 a	 storage	 modulus	 higher	 than	 the	 loss	 modulus	 (G’	 >	 G’’)	 and	 a	
frequency	 independence	 up	 to	 ca.	 25	 Hz.	 Therefore,	 DBS-CONHNH2	 gel	 alone	 and	
incorporating	different	 components	 has	 the	 characteristics	 of	 a	 typical	 gel-like	material	





































higher	 than	 G’’	 again.	 The	 experiment	 was	 repeated	 to	 verify	 its	 reproducibility	 and	 a	
similar	 result	 was	 obtained.	 This	 may	 indicate	 some	 thermal	 reorganisation	 of	 the	
nanofibers	 and	 the	 ability	 to	 self-heal.	 However,	 further	 studies	 would	 need	 to	 be	
performed	to	ensure	that	this	unusual	feature	is	a	characteristic	of	this	gelator.	In	addition,	
an	identical	temperature	dependence	behaviour	up	to	60	°C	is	observed	when	heparin	is	
incorporated	 within	 the	 gel,	 but	 the	 gel	 structure	 becomes	 completely	 lost	 at	
approximately	60	°C.	For	DBS-CONHNH2	gel	with	C16-DAPMA	the	storage	modulus	remains	
higher	than	the	loss	modulus	from	25	to	80	°C,	indicating	a	solid-like	behaviour	of	the	gel	
across	 the	whole	 temperature	 range	 tested,	however	 it	 is	 possible	 to	observe	a	 steady	
decrease	of	G’	with	the	increase	of	temperature	(G’=3.09x103	Pa	at	25°C	and	G’=1.72x103	
Pa	at	80°C),	 indicating	changes	 in	the	viscoelastic	properties	of	 the	gel	and	possibly	the	



































To	 understand	 whether	 heparin	 could	 be	 released	 from	 DBS-CONHNH2	 hydrogels	 and	
determine	how	its	release	could	be	controlled,	different	release	assays	were	performed.	
The	release	of	heparin	from	these	LMWG	hydrogels	is	of	great	importance,	as	it	is	intended	

























heparin	 by	 binding	 it	 into	 hierarchical	 aggregates.	 In	 this	way,	 it	 should	 be	 possible	 to	
trigger	 the	 release	 of	 heparin	 by	 degrading	 the	 binder	 or	 adding	 a	 biocompatible	
competitor	that	will	preferentially	interact	with	the	binder,	hence	releasing	the	heparin.	It	





















on	 top	 of	 the	 hydrogels	 containing	 heparin-C16-DAPMA	 aggregates,	 in	 order	 to	 bind	





































from	10	mM	Tris-HCl/	 150	mM	NaCl	 buffer	 (pH	7.4)	 to	 borax/NaOH	buffer	 (pH	10).	 As	
previously	reported,	DBS-CONHNH2	hydrogels	are	stable	across	a	wide	pH	range,	from	2	to	
11.5,	so	the	change	in	pH	will	not	affect	the	gel	network.88	Additionally,	by	increasing	the	
pH,	 the	 protonated	 C16-DAPMA	 should	 be	 neutralised	 and	 therefore,	 not	 be	 able	 to	






















and	 only	 28%	 release	 in	 the	 presence	 of	 1%	 agarose.	 At	 longer	 times,	 however,	 the	
presence	of	agarose	does	not	show	an	influence	on	the	release,	with	approximately	53%	













































































































used	 in	 the	 laboratory,	as	 there	was	no	 time	during	 the	placement	 to	optimise	 the	cell	







and	 only	 gels	 could	 be	 observed.	 The	 gels	 were	 not	 transparent	 enough	 to	 allow	 the	
visualization	of	the	cells,	as	shown	in	Figure	4.35.	In	addition,	from	the	control	images	it	
















Live/dead	 staining	 was	 performed	 for	 DBS-CONHNH2	 hydrogels	 and	 DBS-CONHNH2	








































can	 adhere	 and	 therefore	 contributing	 to	 cell	 death.	 Nevertheless,	 the	 increase	 of	 the	
metabolic	activity	from	day	1	to	day	7	when	the	cells	were	in	contact	with	DBS-CONHNH2	










































Thus,	 an	 initial	 cell	 density	 of	 25000	 cell/mL	 was	 used,	 together	 with	 lower	 heparin	
concentrations	 of	 50	 µg/mL,	 25	 µg/mL	 and	 10	 µg/mL.263,266	 Additionally,	 the	





uniform	surface,	making	 it	 inappropriate	 to	seed	cells.	Therefore,	C16-DAPMA	was	only	
tested	when	interacting	with	heparin.	From	the	studies	described	above	we	knew	that	it	
was	not	possible	to	obtain	clear	 images	from	optical	and	fluorescence	microscopy	using	



































From	 the	 obtained	 results,	 it	 is	 possible	 to	 verify	 that	 the	 presence	 of	 appropriate	
concentrations	 of	 heparin	 within	 DBS-CONHNH2	 gel	 network	 can	 slightly	 increase	 the	
metabolic	activity	of	the	cells	over	7	days.	The	presence	of	heparin	within	the	gel	matrix	





short	 to	medium	chain	 saturated	 fatty	acids	are	presumably	used	by	cells	as	an	energy	
source,	thus	promoting	cell	growth,	long-chain	saturated	fatty	acids	can	be	involved	in	the	
apoptosis	 of	 cells	 through	 the	 formation	 of	 ceramide,273	 reactive	 oxygen	 species274	 or	
alteration	 of	mitochondrial	membrane	 permeability.275	 Harvey	 et	 al276	 have	 shown	 the	
impact	that	the	chain	length	of	saturated	fatty	acids	can	have	in	endothelial	cell	functions.	




to	 the	 inhibition	 of	 cell	 growth	 when	 incorporated	 in	 DBS-CONHNH2	 hydrogels.	
Alternatively,	the	adverse	impact	may	be	a	result	of	using	an	amine-modified	fatty	acid,	
due	 to	 the	 high	 affinity	 of	 cationic	molecules	 for	 net	 negative	 charge	 cell	 membranes	
(typically	bacteria	and	cancer	cells)	or	even	mainly	neutral	zwitteronic	cell	membranes	(e.g.	
mammalian	cell	membrane	–	only	5-10%	of	negatively	charged	phospholipids	and	90-95%	




most	 likely	 due	 to	 the	 absence	 of	 adhesion	 points	 therefore	 preventing	 cell	 growth.	
Although	 agarose	 is	 known	 for	 being	 biocompatible	 and	 having	 mechanical	 properties	
















used	alone.	However,	 it	was	possible	 to	verify	 that	cells	 could	grow	effectively	on	DBS-













the	 gel	 (Figure	 4.41	 a).282,283	 If	 the	 cells	 migrate	 through	 the	 gel	 they	 will	 cross	 the	


















After	 1	 day	 the	 plates	 were	 observed	 under	 the	 optical	 microscope	 but	 no	 cells	 were	
detected	on	the	bottom	of	the	wells,	except	for	the	control	where	cells	were	added	directly	
into	the	well.	After	7	days	the	same	was	observed	and	therefore,	the	gels	were	removed	






















cells,	 a	 cell	 density	 of	 10000	 cell/mL	was	used.	 The	 cytocompatibility	 of	DBS-CONHNH2	
hydrogels	in	the	absence	and	the	presence	of	heparin	(50	µg/mL,	25	µg/mL	and	10	µg/mL)	
was	studied,	as	well	as	DBS-CONHNH2	in	the	presence	of	C16-DAPMA,	and	the	presence	of	






















may	 indicate	 that	 these	 conditions	 can	 improve	 the	 biocompatibility	 of	 DBS-CONHNH2	
hydrogels	 for	 cells	 to	 adhere	 and	 proliferate.	 Additionally,	 when	 DBS-CONHNH2	 was	
incorporated	 with	 C16-DAPMA	 and	 heparin-C16-DAPMA	 aggregates,	 no	 cells	 were	
observed	 over	 the	 7	 days,	 indicating	 that	 the	 presence	 of	 C16-DAPMA	 is	 toxic	 and	
































Phalloidin/DAPI	 staining	 as	 shown	 in	 Figure	 4.47,	 corresponds	 to	 the	 tests	 performed	
before	the	optimization	of	the	cell	density	due	to	a	malfunction	of	the	computer	connected	
























hydrogels,	 DBS-CONHNH2	 hydrogels	 in	 the	 presence	 of	 heparin	 and	 for	 the	 hybrid	












































Similar	 results	 were	 observed	 when	 DBS-CONHNH2	 was	 incorporated	 with	 heparin	 (50	
µg/mL,	25	µg/mL	and	10	µg/mL)	 (Figure	4.53)	and	when	cells	were	 in	 contact	with	 the	
hybrid	hydrogels	of	DBS-CONHNH2	and	agarose	 in	the	presence	and	absence	of	heparin	


























































For	 additional	 information,	 Figure	4.56	 shows	 the	metabolic	 activity	before	 cell	 density	
optimization	 of	 DBS-CONHNH2	 hydrogels	 in	 the	 presence	 of	 higher	 concentrations	 of	
heparin	(1	mM	-	667	µg/mL	and	2	mM	-	1330	µg/mL).	The	significant	higher	concentrations	
of	 heparin	 resulted	 in	 a	 decrease	 of	 the	metabolic	 activity	 when	 compared	 with	 DBS-
CONHNH2	hydrogels	 alone,	 after	7	days.	 This	 is	 in	 agreement	with	 the	 lower	metabolic	
activity	 obtained	when	 the	 cells	were	 on	 top	 of	 the	 hydrogels	 using	 the	 same	 heparin	
concentrations,	 indicating	 lower	 biocompatibility	 when	 heparin	 is	 used	 in	 excess.	 This	































The	 preparation	 of	 DBS-CONHNH2	 gels	 involves	 the	 heating	 of	 samples	 at	 high	
temperatures	(close	to	the	boiling	point	of	water)	which	creates	harsh	conditions	for	the	
cells	 to	 survive,	with	 gelation	 occurring	within	 seconds.	 Consequently,	 the	 heating	 and	
thereafter	 the	 transfer	 of	 the	 samples	 into	 the	well	 plates	 and	 inserts	 had	 to	 be	 done	
outside	the	cell	culture	hood	with	subsequent	sterilization	by	application	of	UV-light.	The	










































µM.	Moreover,	 it	was	 demonstrated	 that	 the	 presence	of	 C16-DAPMA	 interacting	with	
heparin	 in	 the	hydrogel	network	had	a	 significant	effect	on	 the	 thermal	 stability	of	 the	







gel	 alone.	 This	 indicates	 that	 the	 C16-DAPMA-heparin	 aggregates	 influence	 the	 self-
assembly	of	DBS-CONHNH2	gel	fibers,	changing	its	morphology.	The	mechanical	properties	
of	 the	 hydrogel	 were	 affected	 when	 C16-DAPMA	 alone	 was	 incorporated	 due	 to	 the	
formation	of	foam,	while	the	presence	of	agarose	contributed	to	the	formation	of	stiffer	
and	stronger	gels,	as	expected.	Additionally,	this	study	provides	evidence	that	when	mixing	
heparin,	 C16-DAPMA	 or	 heparin-C16-DAPMA	 aggregates	 with	 DBS-CONHNH2	 into	 one	








incorporating	 heparin-C16-DAPMA	 aggregates,	 contributed	 to	 an	 increase	 of	 heparin	
released	from	the	hydrogel,	which	can	 indicate	that	a	triggered	release	 is	achievable	by	
deprotonating	 the	 positively	 charged	 C16-DAPMA	 that	 consequently	 cannot	 interact	











temperatures.	 2D	 cell	 culture	 assays	 revealed	 that	 DBS-CONHNH2	 hydrogels	 remained	
stable	 in	 the	 plates	 throughout	 the	 7	 days	 of	 experiment	 and	no	 fluctuation	of	 gels	 or	











In	 addition,	 cell	 proliferation	 assays	 confirmed	 that	 DBS-CONHNH2	 hydrogels	 are	 not	
cytotoxic,	and	again	the	presence	of	10-50	µg/mL	of	heparin	could	improve	the	metabolic	
activity	of	the	cells.	In	contrast,	the	use	of	higher	concentrations	of	heparin	(667	µg/mL	and	
1330	µg/mL)	proved	 to	have	 the	opposite	 influence,	with	metabolic	 activity	decreasing	
significantly,	 indicating	 that	 the	 concentration	 of	 heparin	 incorporated	 within	 the	 gel	
network	is	crucial	to	support	and	promote	cell	growth.	
	


















the	 influence	 of	 pH	 of	 release	 medium	 in	 triggering	 heparin	 release	 from	 the	 gel.	
Additionally,	the	release	assays	could	be	adapted	and	designed	in	order	to	mimic	the	gel	



























consisting	 of	 a	 triamide	 cyclohexane	 gelating	 scaffold	 with	 the	 addition	 of	 amino	 acid	






















low	 concentrations	 due	 to	 the	 presence	 of	 phenylalanine	 amino	 acids	 that	 provide	
hydrophobic	interactions	fundamental	for	the	gelation	of	water.296	OG2	was	designed	as	a	
LMWG-drug	conjugate	 system.	Specifically,	 it	 is	a	pH	 responsive	gelator	connected	 to	a	
phenylalanyl-aminoquinoline	 that	 can	 be	 enzymatically	 cleaved,	 releasing	 the	
aminoquinoline	group,	through	the	hydrolysis	of	the	amide	into	an	amine.298	The	OG2	gel	
forms	on	raising	the	pH	as	the	protonated	aminoquinoline	 is	converted	 into	the	neutral	












































































[Heparin]	(µM)	 [C16-DAPMA]	(µM)	 Gel	Formation	 Charge	ratio	+/-	

























[Heparin]	(µM)	 [C16-DAPMA]	(µM)	 Gel	Formation	 Charge	ratio	+/-	
150	 Below	600	 Stable	gel	 2	
300	 Below	1200	 Stable	gel	 2	
400	 Below	1600	 Stable	gel	 2	




The	 thermal	 stability	 of	 the	 gels	 formed	 in	 the	 previous	 sections	 was	 tested	 by	 the	
“dropping	ball	method”,	where	a	steel	ball	is	placed	on	top	of	the	gel	and	the	temperature	







(0.5%	 w/v)	 in	 water	 presented	 a	 Tgel	 value	 of	 65	 °C.	 The	 incorporation	 of	 different	
concentrations	of	heparin,	C16-DAPMA	and	heparin/C16-DAPMA	aggregates	 resulted	 in	





as	 the	 same	Tgel	 range	 as	 for	 the	 gel	 alone,	 indicating	 that	 heparin	does	not	 appear	 to	
significantly	affect	the	thermal	stability	of	OG2	gels.	When	C16-DAPMA,	or	heparin	bound	









TEM	 images	 of	 the	OG1	 gel,	 the	OG1	 gel	 in	 the	 presence	 of	 heparin,	 as	well	 as	 in	 the	





















clear	 images.	 It	 was	 difficult	 to	 identify	 the	 gel	 nanofibers	 and	 for	 that	 reason,	 all	 the	


































significantly	affected	by	 the	presence	of	heparin	and	no	 interactions	are	believed	 to	be	
happening	between	the	gelator	and	the	heparin.	On	the	other	hand,	when	C16-DAPMA	
was	incorporated	into	the	OG2	gel	network,	two	different	nanofiber	morphologies	were	
identified,	as	 shown	 in	Figure	5.11,	with	no	visible	presence	of	 the	self-assembled	C16-
DAPMA	micelles.	While	the	unbranched	long	nanofibers	were	still	present	(5.2	±	0.2	nm	in	
diameter);	branched	and	shorter	nanofibers	were	also	observed	(9.2	±	0.7	nm	in	diameter).	
This	 may	 indicate	 that	 the	 C16-DAPMA	 is	 not	 self-assembling	 into	 micelles	 and	 may	
coassemble	 with	 the	 OG2	 molecules	 contributing	 to	 the	 different	 morphology	 being	
observed.309	This	is	consistent	with	the	observation	that	C16-DAPMA	lowers	the	Tgel	value	
of	 OG2	 as	 described	 above	 and	 suggests	 this	may	 be	 underpinned	 by	 a	morphological	
change.	
	
When	both	heparin	 and	C16-DAPMA	were	 incorporated	within	 the	 gel	 network	 (Figure	
5.12)	it	was	possible	to	observe	the	presence	of	aggregates	along	with	OG2	nanofibers	(7.5	
±	1.2	nm	in	diameter).	However,	in	these	aggregates,	the	presence	of	the	well-organized	
hierarchical	 nanostructures	 characteristic	 of	 C16-DAPMA	 interacting	 with	 heparin	 (as	
described	in	Chapter	2)	were	not	observed,	and	it	was	therefore	not	possible	to	confirm	
that	the	interactions	remain	intact.	Additionally,	it	is	noticeable	that	the	presence	of	the	
heparin/C16-DAPMA	aggregates	 somewhat	 influenced	 the	 length	of	 the	 fibers,	 that	are	




























for	 0.5%	 w/v	 OG1	 hydrogels	 was	 measured	 and	 is	 presented	 on	 Figure	 5.13.	 The	
















Figure	5.14	 follows	the	change	 in	 rheological	performance	of	OG1	over	 time	and	hence	
shows	the	gelation	kinetics	of	OG1	hydrogels.	As	the	gelation	of	OG1	occurs	within	seconds,	
when	the	measurement	was	started	the	gel	was	already	formed	and	thus	a	constant	G’	
value	 was	 obtained.	 Only	 for	 the	 sample	 containing	 heparin	 and	 C16-DAPMA	 was	 it	
possible	to	observe	an	increase	of	G’	from	608	Pa	at	0	minutes	to	1281	Pa	at	5	minutes,	
indicating	that	the	incorporation	of	the	hierarchical	aggregates	may	slightly	slow	down	the	































when	 1.2	 mM	 of	 C16-DAPMA	 was	 present	 within	 the	 gel	 the	 LVR	 decreased	 to	
approximately	1%	strain,	indicating	that	the	incorporation	of	C16-DAPMA	contributes	to	a	




































































influence	 of	 agarose	 when	 added	 to	 OG1/OG2	 hydrogelators	 to	 form	 hybrid	 gels	 and	









































The	 same	 experiment	 was	 performed	 to	 verify	 how	 heparin	 release	 is	 affected	 when	
incorporated	 into	a	hybrid	hydrogel	 consisting	of	0.5%	w/v	OG1	as	 LMWG	and	1%	w/v	



































cylinder	was	 immersed	 in	 buffer.	When	using	 the	OG1-agarose	 hybrid	 gel	 cylinder,	 the	

























































may	be	a	 result	of	 the	change	 in	morphology	of	 the	OG1	nanofibers	 in	 the	presence	of	
heparin	observed	by	TEM,	with	the	junction	of	the	fibers	into	a	needle	shape	contributing	

























Surprisingly,	 the	 use	 of	 agarose	 to	 prepare	 hybrid	 hydrogels	 with	 OG2	 resulted	 in	 the	
formation	of	 very	unstable	 gels	or	partial	 gels.	 Therefore,	 it	was	not	possible	 to	obtain	





A	 different	 approach	 to	 release	 heparin	 in	 a	 controlled	 manner	 involves	 the	 direct	
interaction	 of	 heparin	 with	 negatively	 charged	 nanofibers	 that	 can	 degrade	 or	 can	 be	




charged	 Cu(OH)2	 nanofibers	 by	 electrostatic	 interactions.	 The	 system	 exhibited	 good	






































OG+	 hydrogels	 (0.5%	 w/v)	 could	 be	 obtained	 using	 two	 different	 approaches,	 one	 by	
acidifying	the	gelator	solution	in	water,	with	HCl	(1	M),	to	completely	dissolve	the	gelator,	
followed	by	neutralisation	of	the	solution	by	NaOH	(1	M)	and	the	other	by	dissolving	the	






and	 elongated	 nanofibers	 having	 a	 diameter	 of	 6.8	 ±	 0.8	 nm.	 When	 heparin	 was	
incorporated	within	the	gel	 it	was	possible	to	observe	the	presence	of	needle-like	semi-
crystalline	structures	that	may	correspond	to	heparin	(Figure	5.23	-	top).	When	obtaining	
more	detailed	 images	of	 these	nanostructures	 (Figure	5.23	 -	bottom)	 it	was	possible	 to	
clearly	 observe	 the	 presence	 of	 what	 appear	 to	 be	 nanofibers	 wrapped	 around	 larger	
fibrillar	 objects.	 In	 a	 first	 conclusion,	 it	 appears	 that	 these	 are	 OG+	 nanofibers	 that	






















The	 OG+	 gelator	was	 designed	 so	 it	 can	 bind	 directly	 to	 heparin	 and	 be	 enzymatically	
cleaved	by	a-chymotrypsin	(a-chy),	resulting	in	the	release	of	heparin.	Therefore,	heparin	
release	 from	OG+	hydrogels	was	 tested	by	using	1	mL	of	gel	 samples	 (1:9	DMSO:buffer	
preparation	method)	and	placing	1	mL	buffer	on	top	of	the	hydrogels.	Aliquots	of	buffer	
















requirement	 for	 C16-DAPMA	 assemblies	 to	 be	 present.	 Moreover,	 as	 the	 heparin	















































was	 investigated.	With	 respect	 to	 the	OG1	hydrogel,	 the	presence	of	heparin	 and	C16-
DAPMA	 contribute	 to	 different	 nanofiber	 morphologies,	 however	 with	 no	 evident	
influence	in	the	stability	of	the	gels	(similar	Tgel	and	LVR	values).	On	the	other	hand,	the	
incorporation	 of	 C16-DAPMA	 or	 heparin	 bound	 to	 C16-DAPMA	 in	 OG2	 hydrogels	












and	 thus	controlling	 the	 release	of	heparin	 from	OG1	hybrid	hydrogels	by	changing	 the	












heparin	 was	 inhibited	 by	 this	 gel-binding	 event	 and	 was	 only	 achievable	 by	 enzymatic	



















acids	was	 reported	and	 their	 ability	 to	bind	 to	heparin	was	 investigated.	Modifying	 the	
hydrophobic	chain	length	offers	a	mechanism	for	tuning	the	ability	of	these	compounds	to	
self-assemble	into	micellar	aggregates,	with	C16-DAPMA	being	the	optimal	system	in	terms	




cylindrical	 heparin	 were	 structurally	 characterised.	 In	 particular,	 C14-DAPMA	 and	 C16-
DAPMA	 formed	 highly	 organised	 nanocrystalline	 assemblies	 as	 observed	 by	 TEM.		
Characterisation	by	mesoscale	simulations	and	SAXS	further	confirmed	that	the	micelles	
remained	 intact	 during	 hierarchical	 assembly	 and	were	 packed	 in	 a	 face-centred	 cubic	
manner	on	contact	with	heparin.	 	The	assemblies	formed	by	the	most	effective	system,	
C16-DAPMA	 showed	 the	 highest	 degree	 of	 crystalline	 order	 revealed	 by	 the	 distinct	




In	 Chapter	 3,	 a	 simple	 multi-component	 approach	 to	 hybrid	 hydrogels	 with	 two	 self-
assembling	 components	 (DBS-COOH	 and	 C16-DAPMA)	 and	 two	 polymeric	 components	




However,	 if	 the	 heparin	 is	 bound	 to	 self-assembled	multivalent	 C16-DAPMA,	 then	 the	
assembly	 of	 DBS-COOH	 still	 takes	 place,	 and	 although	 the	 presence	 of	 the	 hierarchical	

















the	 incorporation	of	heparin,	C16-DAPMA	and	agarose.	However,	 if	heparin	 is	bound	to	
C16-DAPMA	 the	 morphology	 of	 the	 gel	 fibers	 is	 affected,	 although	 the	 hierarchical	
organised	nanostructures	of	heparin-C16-DAPMA	aggregates	remain	intact	within	the	gel	
network.	 When	 the	 PG	 is	 present,	 DBS-CONHNH2	 self-assembly	 is	 unaffected	 and	 it	
contributes	to	the	formation	of	robust	gels.	The	release	of	heparin	from	the	DBS-CONHNH2	





50	 µg/mL	 of	 heparin	 was	 incorporated	 within	 the	 gel	 network.	 However,	 C16-DAPMA	
















due	 to	 deprotonation	 of	 the	 heparin	 binder	 as	 the	 gel	 is	 formed	 by	 basification.	
Additionally,	a	positively	charged	cyclohexane-based	LMWG	–	OG+	was	introduced.	OG+	
directly	binds	to	heparin	as	a	consequence	of	its	positive	charge,	as	demonstrated	by	TEM	
images,	 and	 its	 triggered	 release	 can	 be	 obtained	 by	 enzymatic	 cleavage	 of	 the	 OG+	
hydrogel.		
	






As	 future	work,	 triggered	heparin	 release	under	physiologically	 relevant	 conditions	 and	
multi-component	 hybrid	 gels	 should	 be	 studied,	which	 ultimately	may	have	 biomedical	
applications.	Studies	can	proceed	to	further	explore	the	pH	responsiveness	of	DBS-COOH	
and	 OG2	 hydrogels	 to	 release	 bioactive	 molecules	 by	 testing	 different	 bases	 or	 acids,	
respectively.	Different	heparin	binders,	such	as	cholesterol-based	SAMul	binders,	can	also	
be	 tested	 in	order	 to	optimise	 the	cytocompatibility	of	 the	multi-component	hybrid	gel	
systems	while	enabling	a	triggered	release	response	through	degradation	of	the	binders.	















All	 reagents	 were	 purchased	 from	 commercial	 sources	 and	 used	 directly	 without	 any	
further	 purification,	with	 the	 exception	 of	MalB	 dye	which	was	 synthesised	 in	 the	DKS	
laboratory	 following	 known	 methods.225	 Heparin,	 sodium	 salt,	 from	 porcine	 intestinal	
mucosa	(MW	13,500-15,000	Da)	was	purchased	from	Merck.	a-Chymotrypsin	from	bovine	
pancreas	 (MW	40,000	Da)	was	purchased	 from	Sigma.	Thin	 layer	chromatography	 (TLC)	
was	 performed	 on	Merck	 aluminium-backed	 plates	 coated	 with	 0.25	 nm	 silica	 gel	 60.	
Preparative	 gel	 permeation	 chromatography	 (GPC)	 was	 performed	 on	 Biobeads	 SX-1	
supplied	by	Bio-Rad.	ESI	mass	spectra	were	recorded	on	a	Bruker	Daltonics	Micro-Tof	mass	
spectrometer.	 Fluorescence	 spectra	 were	 obtained	 with	 a	 Hitachi	 F-4500	 fluorimeter.	






(1H	 500	 MHz)	 and	 a	 Jasco	 J810	 CD	 spectrophotometer.	 DLS	 and	 zeta	 potential	
measurements	 were	 recorded	 on	 a	 Zetasizer	 Nano	 ZS.	 SAXS	 was	 performed	 by	 Ville	
Liljeström	 at	 the	 Department	 of	 Applied	 Physics,	 School	 of	 Science,	 Aalto	 University	






































(NCH3);	 38.89	 (CH2NHCO);	 38.74	 (CH2NH2);	 31.16	 (CH2CH2NHCO);	 28.78	 (CCH3);	 27.72	


















Myristic	 acid	 (1.00	 g,	 4.40	mmol)	was	 dissolved	 in	 DCM	 (65	mL).	 O-(Benzotriazol-1-yl)-
N,N,Nʹ,Nʹ-tetramethyluronium	 tetrafluoroborate	 (TBTU)	 (1.41	 g,	 4.40	 mmol)	 and	














36.16	 (CH2NHCO);	 35.52	 (CH2CONH);	 31.99,	 29.74,	 29.44	 (all	CH2);	 28.42	 (CCH3);	 25.79,	




































36.21	 (CH2NHCO);	 35.76	 (CH2CONH);	 31.99,	 29.78,	 29.43	 (all	CH2);	 28.42	 (CCH3);	 25.81,	




































24.86,	 24.57,	 22.75	 (all	CH2);	 14.19	 (CH3CH2).	 νmax	 (cm-1)	 (solid):	 3404m,	 2917s,	 1649m,	









































































































































142.64	 (Ar-C);	 130.97	 (Ar-C);	 130.91	 (Ar-C);	 129.17	 (Ar-C);	 129.08	 (Ar-C);	 126.31	 (Ar-C);	
98.65	(Acetal-C);	98.57	(Acetal-C);	77.58	(CH);	70.16	(CH);	69.32	(CH2);	69.04	(CH);	68.51	























DBS-COOCH3	 (1.10	 g,	 2.32	mmol)	 was	 dissolved	 in	 tetrahydrofuran	 (40	mL).	 Hydrazine	
monohydrate	(6.19	g,	0.12	mol)	was	added	to	the	solution	and	the	mixture	was	heated	
overnight	 at	 65	 °C	 under	 reflux.	 The	 product	was	 then	 filtered,	washed	with	 deionised	
























Red	 was	 added	 to	 all	 the	 cuvettes.	 The	 fluorescence	 was	 recorded	 with	 an	 excitation	
wavelength	 of	 550	 nm	 and	 an	 emission	 wavelength	 of	 635	 nm.	 The	 procedure	 was	



















DLS	 measurements	 were	 carried	 out	 at	 25	 oC,	 in	 triplicate	 with	 11-15	 runs	 per	 single	




















Zeta	potential	measurements	were	obtained	using	 the	 samples	previously	prepared	 for	
DLS.	The	samples	were	transferred	to	a	zeta	capillary	cell	(DTS1070)	until	the	electrodes	





In	order	 to	obtain	TEM	 images,	10	µL	of	each	sample	 (Table	7.2)	 in	ultra-pure	H2O	was	
placed	on	a	copper	grid	(standard)	with	Formvar	and	carbon	support	film.	Excess	sample	
































size	at	 the	 sample	position	was	 roughly	1	mm	 in	diameter.	The	 scattered	 intensity	was	
collected	using	a	Hi-Star	2D	area	detector	(Bruker).	Sample-to-detector	distance	was	0.59	
m,	 and	 silver	 behenate	 standard	 sample	 was	 used	 for	 calibration	 of	 the	 length	 of	 the	
scattering	vector	q.	One-dimensional	SAXS	data	were	obtained	by	azimuthally	averaging	























binder	 stock	 solution	 was	 additionally	 endowed	 with	 a	 heparin	 concentration	










































three	 times	 higher	 concentration	 than	 the	 intended	 final	 concentration,	 to	 allow	 for	
subsequent	dilutions.	0.5	mL	of	C16-DAPMA	solution	(600	µM)	was	then	added	to	0.5	mL	
of	heparin	solution	(152	µM)	and	stirred	to	ensure	the	binding.	The	previous	mixture	was	




































DBS-COOH	gel	was	prepared	with	 solutions	 containing	a	 fixed	concentration	of	heparin	
(150	µM)	and	different	C16-DAPMA	concentrations	(100	µM;	150	µM;	200	µM;	250	µM;	
300	µM;	350	µM;	400	µM;	450	µM;	500	µM;	600	µM).	0.5	mL	of	10	mM	Tris-HCl/	150	mM	
NaCl	 (pH	7.4)	was	added	 to	DBS-COOH	powder	 (2.0	mg)	and	sonicated.	30	µL	of	0.5	M	
NaOH(aq)	 was	 added	 to	 dissolve	 all	 solid.	 A	 solution	 of	 C16-DAPMA	 and	 heparin	 was	









powder	 (2.0	mg)	 and	 sonicated	 for	 20	min.	A	 solution	of	C16-DAPMA	and	heparin	was	





























































































































DBS-COOH	 (Table	7.5)	and	DBS-CONHNH2	 (Table	7.6)	gel	 samples	 for	TEM	 images	were	
prepared	 in	 ultra-pure	 H2O	 and	 images	 obtained	 by	 adding	 one	 microspatula	 of	 each	




















































DBS-COOH	 (0.2%	 w/v,	 2%	 w/v,	 5%	 w/v	 and	 10%	 w/v)	 and	 DBS-CONHNH2	 (0.4%	 w/v)	
hydrogels	(3	mL)	containing	1	mM	of	heparin;	1	mM	of	heparin	and	2	mM	of	C16-DAPMA;	
and	agarose	(0.5%	w/v	and	1%	w/v)	with	heparin	(1	mM)	were	prepared	in	10	mM	Tris-





























































































for	 1h.	 Triton-X100	 was	 removed	 and	 the	 samples	 washed	 twice	 with	 DPBS	 for	
approximately	15	min.	The	plates	were	incubated	overnight	at	4	°C	with	100	µL	or	200	µL	





































Different	 volumes	 (100	µL,	 80	µL	 and	60	µL)	 of	DBS-CONHNH2	hydrogels	 (0.4%	w/v)	 in	
transwells	were	 prepared	 as	 described	 above.	 Cells	 (cell	 density:	 10000	 cells/mL)	were	








The	OG1	 gel	was	 prepared	by	 adding	 1	mL	of	water	 into	 5	mg	of	 gelator	 powder.	 The	




mL	 of	 HCl	 (1	M)	was	 added	 to	 completely	 dissolve	 the	 gelator.	 The	 solution	was	 then	






mL	of	heparin	 solution	 into	5	mg	of	 gelator	powder.	 The	 solution	was	heated	until	 the	

















OG1	 and	 OG2	 gels	 were	 prepared	 with	 solutions	 containing	 a	 fixed	 concentration	 of	
heparin	 and	different	 C16-DAPMA	 concentrations.	 An	 initial	 charge	 ratio	 (+/-)	 of	 2	was	






prepared	 in	 a	 2	mL	 glass	 vial.	 The	 vial	was	 subsequently	 placed	 in	 a	 heating	 block	 and	































plate	 of	 the	 rheometer	 that	 was	 previously	 heated.	 The	 sample	 was	 heated	 on	 the	
rheometer	plate,	followed	by	decreasing	the	temperature	to	25°C.		
	







The	 viscolelastic	 properties	 of	 OG1	 and	 OG2	 hydrogels	 were	 measured	 by	 applying	 a	
dynamic	 strain	 sweep	 (f	 =	 1Hz)	 and	 a	 dynamic	 time	 sweep	 (f	 =	 1	 Hz,	 Y	 =	 0.5%).	 The	
measurements	were	carried	out	with	a	parallel	geometry	plate	(d	=	40	mm)	and	a	gap	of	
0.8	mm.	The	same	procedure	was	performed	for	OG1	and	OG2	hydrogels	 incorporating	

















completely	dissolve	 the	gelator.	 The	 solution	was	 then	neutralised	by	adding	0.1	mL	of	
NaOH	 (1	M)	and	gently	 shaken.	 The	gel	 formation	was	observed	 immediately	 after	 the	
neutralisation	of	the	gelator	solution.	In	a	second	approach,	5	mg	of	gelator	was	dissolved	
in	0.1	mL	of	DMSO,	followed	by	the	addition	of	0.9	mL	of	0.1	M	Tris-HCl	buffer,	pH	7.75	











































1D	 	 	 One-dimensional	
2D	 	 	 Two-dimensional	
3D	 	 	 Three-dimensional	
a-chy		 	 	 a-	chymotrypsin	
A	 	 	 Alanine	
AgNPs	 	 	 Silver	nanoparticles	
AM		 	 	 Acetoxymethyl	
ASC	 	 	 Adipose	tissue	derived	stem	cells	
AuNPs	 	 	 Gold	nanoparticles	
BMP-2		 	 Bone	morphogenic	protein-2	
Boc	 	 	 tert-Butyl	Dicarbonate  
br	 	 	 broad	(NMR) 	
CD	 	 	 Circular	Dichroism	
CE50	 	 	 Charge	excess	
CGC	 	 	 Critical	Gelation	Concentration	
ChS-F	 	 	 Chondroitin	sulfate	
CMC	 	 	 Critical	Micelle	Concentration	
CN	 	 	 Cavernous	nerve	
D	 	 	 Aspartic	acid	
d	 	 	 doublet	(NMR)	
DAPI	 	 	 4',6-diamidino-2-phenylindole	
DAPMA	 	 N,N-Di-(3-aminopropyl)-N-methylamine	




DCM	 	 	 Dichloromethane	







DOPC	 	 	 Dioleoylphosphocholine	
DPBS	 	 	 Dulbecco’s	phosphate	buffered	saline	
DPD	 	 	 Dissipative	Particle	Dynamics	
E	 	 	 Glutamic	Acid	
EC50	 	 	 Effective	concentration	
ECM	 	 	 Extracellular	matrix	
EGF	 	 	 Epidermal	growth	factor	
FBS	 	 	 Fetal	bovine	serum	
FDM	 	 	 Fibroblast-derived	extracellular	matrix	
FGF	 	 	 Fibroblast	growth	factor	
FGFR	 	 	 Fibroblast	growth	factor	receptor	
Fmoc	 	 	 9-fluorenylmethoxycarbonyl	
Fmoc-FF	 	 Fmoc-diphenylalanine	
G’		 	 	 Storage	or	elastic	modulus	
G’’	 	 	 Loss	or	viscous	modulus	
GAG	 	 	 Glycosaminoglycans	
GdL	 	 	 Glucono-d-lactone	
GF	 	 	 Growth	factors	
GNF	 	 	 Glycosyl-nucleosyl-fluorinated	
GPC	 	 	 Gel	permeation	chromatography	
HCEC	 	 	 Human	corneal	endothelial	cells		
HUVEC		 	 Human	umbilical	vein	endothelial	cells	
IR	 	 	 Infrared	
K	 	 	 Lysine	
LMWG		 	 Low	molecular	weight	gelator	
LMWH		 	 Low-molecular-weight	heparin	
LVR	 	 	 Linear	viscoelastic	region	
m	 	 	 medium	(IR)	
m	 	 	 multiplet	(NMR) 	
MalB	 	 	 Mallard	Blue	
MDP	 	 	 Multidomain	peptide	






NMR	 	 	 Nuclear	Magnetic	Resonance		
PA	 	 	 Peptide	amphiphile	
PBS	 	 	 Phosphate	buffer	saline	
PdI	 	 	 Polydispersity	index		
PEG	 	 	 Poly(ethylene	glycol)	
PEG-AMI	 	 Maleimide-terminated	poly(ethylene	glycol)	
PEGDM	 	 Poly(ethylene	glycol)	dimethacrylate	
PFA	 	 	 Paraformaldehyde	
PG	 	 	 Polymer	gelator	
PlGF-1	 	 	 Placental	growth	factor-1	
P/S	 	 	 Penicillin/Streptomycin	
p-TsOH	 	 p-Toluenesulfonic	acid		
q	 	 	 quartet	(NMR) 	
RGD	 	 	 Arginine-glycine-aspartic	acid		
s	 	 	 strong	(IR)	
s	 	 	 singlet	(NMR)	
SAMul	 	 	 Self-assembling	multivalency	
SAXS	 	 	 Small	Angle	X-Ray	Scattering	
SDS	 	 	 Sodium	dodecylsulfonate	
SDBS	 	 	 Dodecylbenzenesulfonate	
SEM	 	 	 Scanning	Electron	Microscopy	
SHH	 	 	 Sonic	hedgehog	
t	 	 	 triplet	(NMR) 	
TBTU	 	 	 O-(Benzotriazol-1-yl)-N,N,Nʹ,Nʹ-tetramethyluronium	
tetrafluoroborate	
TEM	 	 	 Transmission	Electron	Microscopy	
Tgel	 	 	 Critical	gelation	temperature	
TGFb	 	 	 Transforming	growth	factor	beta		
TLC	 	 	 Thin	layer	chromatography	
TRITC	 	 	 Tetramethylrhodamine	B	isothiocyanate	






VEGF	 	 	 Vascular	endothelial	growth	factor	
w	 	 	 weak	(IR)	
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